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ABSTRACf
Vascular endothe lial cells respond to certa in vasoactive agents by re leasing
factorswhichactonmedial smooth muscletocauserelaxation or contractionof blood
vessels. One of the substances responsible for endothelium-dependent relaxation
to acetylcholine has recently been identified as nitric oxide. We have tested the
hypothesis that the ability of vascular endothelium to cause relaxation in response
to stimulation by vasoactive agents is related in some way to the pattern of
perivascular innervation. The actions of acetylcholine and substance P were tested
in the presence of methoxamine induced lone in the isolated perfused mesenteric
ar terial bed of the rat. T issues were tested from untreated normal J2 week old
Sprague-Dawley rats and from rats which had been treated from birth with capsaicin
to prevent the development of peptidergic perivascular innervation or 6-
hydroxydopamine to prevent development of catecbcla mlnerglc innervation.
Concentration depe ndent endothelium-dependent relaxations were observed in
response to acetylcholine. The concentration response curve to acetylcholine was
shifted 1.2 log units to the right in the capsaicin-treated gro up but no change was
observed with 6-hydroxydopam ine treatment. Substance P caused a r'ose dependent
potent iation of the methoxamine induced tone which was not dependent on the
presence of an intact endothe lium. Relaxations to substance P were not observed
at anydose. Sympathectomywith neonatal 6-0 HDA treatment resulted in an increase
in the substance P pressor response, but no changeswere observedwithcapsaicin
treatment. Thus, it appears that altering the peptidergie perivascular innervation
results in a decreased sensitivity of the mesenteric arterial bed to acetylcholine and
changes in the catechclaminergic fibre plexus result in an enhancement of the
substanceP modulation of adrenergic vasoconstriction.
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INTRODUcnON
1.1. The Control of Vascular Tone
The control of the cardiovascular system involves a variety of components
which influe nce smooth muscle tone . The distribution of blood 10 tissues in the body
is determfned by the flow of blood from the heart and the regulation of blood
vessel diameter. The complex system responsible for this function includes the
innervation of the vasculature, circulating factors in the blood, and the endothelium.
1.1.1. Vascular Innervation
One of the most powerful mechanisms for the overall control of the
cardiovascular system is the innervation providedby the autonomicnervous system.
The nerve fibres whichsupply the bloodvessels are calledperivascular nervessince
they form a mesh-like termi nal pi CKUS at the adven titial-medial border of the blood
vessel wall.
For a long time the innervation of the vasculature was thought 10 consist of
sympathetic nerves containing catechotamlnes. However, with the development of
immunological techniques capable of identifying and defining neurotransmitter
substances, these fibre networks havebeen shown to be more complex(Kenigsberg
and Cuello, 1987). Three different types of perivascular nerves, adrenergic,
cholinergic, and peptldergtchavebeen distinguished. In addition, somenervefibres
have been shownto containmore than one of these typesof neurotransmitter co-
localized at the nerve terminals(Hckfeltet aL, 1987).
(a) AdrenergicInnervation of the Vasculature
The mostimportantcomponentof autonomicmotorcontrolofthe vasculature
is Ihe sympathetic nervous system, in which noradrenaline is the peripheral
neurotransmitter. The adrenergicnervesupply10mostvessels inthebodyoriginates
in the pre- or pare-vertebra! ganglia of the sympathetic nervous system. However,
the innervation of some blood vessels in the brain may originate in central
carechclaminergic neurons(Edvinsson et aL, 1973).
There is a great variation in the pattern and densityof the sympathetic
innervation of vascular smooth muscle (Burnstock, 1975). It is likely that such
variation is related to the physiological role of the blood vessel in the tissue it
supplies. In general, large elasticarteriesshowa sparse pattern of innervationand,
as the sizeof the arterydecreases,the densityof innervation increases. Capillaries,
venules and smallveinsare considered to have very little adrenergicnervesupply.
Veinsusuallyhave a much lessdense innervation than arteries.
(b) Cholinergic Innervation of the Vasculature
Innervation of blood vessels by postganglionic cholinergic nerve fibres is
generally thought to provide an inhibitory control of vascular tone. However, the
nature of this vasodilatoryaction is understood less than the actions of adre-e rgic
nerves. These cholinergic nerves have a less widespread distribution in the
cardiovascular system than do the sympathetic fibres. However, physiological and
histochemical studies havesuggested the possibilityof cholinergicvasomotor control
in the brain,heart, lung,kidney,skeletal muscle and uterus (Schenk and EI Badawi,
1968; Bell,1969; Iwayama et al.,1970; Borodulya and Pletcbkcva,1973). Thus, some
vascular beds possessa dual adrenergic and cholinergic lnnervadon.
Cholinergic nerves in the blood vessels o~ skeletal muscle originate from
ganglia of the sympathetic chain,while those of the uterine arteryarise from the
paracervical ganglion. The originof the cholinergicsupplyto the intracranial blood
vessels is not yet known. Vesselsofthe gastrointestinal tract receive their cholinergic
nerve supplyfrom the intramuralganglia (Owman, 1983).
(c) Peptidergic Innervation of the vasculature
In addition to the sympathetic adrenergic and parasympathetic cholinergic
divisions of the autonomic nervoussystem, a network of peptidergicnerves which
innervate the vasculature of a range of mammals, including man, has been shown
to exist (FurnessesaL, 1984). A varietycf small peptides, with up to about 40amino
acid residues, have been found in peripheral nerves which supply autonomically
innervatedorgans(Hokfelt el ai, 1980; Furness d al, 1982;Furnessand Costa, 1982).
Within the cardiovascular system, the distnbu tion of the peptides appears to vary
from bedto bed and fromone speciesto another. While manyof the pep tides heve
been foundin thecardiovascularsystem,those mostcommonlyinvolved are substance
P (SP). calcitonin gene-related peptide (CGRP), neuropeptide Y (NPY) and
vasoactive int estinal polypeptide (VIP).
Substance P
Among the peptides listed. SP has perhaps the longest history. It was first
descnbed as a biologically active compound in crude gut extractsbyvon Euler and
Gaddum in 1931. It was not until 1971that Chang and co-workers isolated SP in
its pure form from bovine hypothalamus and estab!:.:hed the eleven amino acid
sequenceof the peptide. Shortly thereafter the peptide wassynthesizedsuccessfully
(Tregear el al , 1971). Then, the availabilityof a pure andchemicallydefined SP
made it possible togenerate specificantibodies to the peptide for radioimmunoassay
and immunohistochemistry.
Substance P has a widespread distribution in the central and peripheral
nervous systems in a variety of species. including man (Furness et aJ., 1984).
Extensive studies have establishedthe presence of SP in most parts of the central
nervoussystemof all mammals. Detailedradioimmunoassay studies have indicated
that the highest concentrationsare present in the mesencephalon,hypothalamus and
preopticarea.while the cerebellumcontainsinsigni6cantamountsof SP(Brownstein
etat. 1976;Kanazz.wa and Jessen, 1976; Gale etaL,1978;Emscna aL,1980;Cooper
a aL, 1981). Immunohistochemical mapping has so far identified SP in over 30 areas
of the brain including the brain stem and spinal cord. For a thorough account of
studieswhich have been done to localize SP in the central nervoussystem the reader
is referred to Pcrnow (1983).
In the periphery substance P is mainly in sensory nerves with a widespread
distributionto the heart and mostvascular beds. Insome animalssuch as the guinea-
pig, virtuallyall vascular beds are supplied with SP-containing nerve fibres. The
presence of SP fibres has been demonstrated in the guinea-pigheart (Wharton et
aL, 1981a), rat carotid sinus (Helkeet aL, 1980), and in the arteries and veinsof the
tracheobronchialtissueof the guinea-pig(SundleretaL, 1977). lmmunohistochemical
studies have also identified substance P-like immunoreactive(SPLI) nerves in the
guinea-pig aorta and pulmonary artery(Reinecke et aL, 1980) and in the vessels of
the urinary and reproductive systems (Aim et aL, 1978; Wharton et 01., 1981b).
SubstanceP fibres have beenshownto innervate the cerebral (Liu-Chenet aL, 1986),
coronary (Brumet 01., 1986) and mesenteric vascular beds (Scott €I aL, 1989).
Both vasomotor and sensory functions have been suggested 00account for
the presence ofSP-fibres in bloodvessels. In coronary. pulmonary, mesenteric, renal
and cerebral bloodvessels SP hasbeen shownto causevasodilation (Maxwen.1968;
Hallbergand Pemcw, 1975;Ek.lund el at, 19'n) . Vasoconstrictionby SP hasbeen
reported in the hepatic portal vein of the rat (Hellstrand and Jarhult, 1980;
Mastrangeloet aL, 1980) and the anterior mesenteric vein of the rabbit (Berube et
aL,1978). A sensoryfunction Cor SP in vascular nerve fibreshas alsobeen suggested,
since pretreatment with capsaicin eliminates SP-like immunoreactivity from these
fibres (Furness et 01., 1982: Matthewsand Cuello, 1982).
Calcitonin Gene-Related Peptide
Calcitonin gene-related peptide(CGRP) is a :17·amino acidpeptide resulting
from alternative processing of the RNA during expression of the calcitonin gene
(Amara et al , 1982; Rosenfeld et at, 1983). The exi..tence of CGRP was flt'$ t
predicted by analysis of a new RNA in a rat cell line. A similar peptide was
subsequently isolated from human medullary carcinoma of thyroid tissue and
sequenced in 1984 (Morris et a; 1984). CORP has been shown to have strong
vasodilatoryactions (Brain et aL, 1985). It exerts its vasodilatoryeffect both through
direct inlluence on vascular smooth muscle and by inhibition of neurogenic
vasoconstriction (Brain ct al, 193.5; FISCher et aL, 1983; Hanko et al , 1985).
Immunohistochemical studieshaveshowna widespread distributionof CGRP
insensoryneuronesand nervefibresof the cardiovascular system of several species
(Wharton and Gulbenkian, 1987). Many studies have been done in guinea-pig
whereperivascular CGRP fibreshavebeen seen in allvascular beds. lnan extensive
studybyUddmanandco-workers (1986), the distributionofperivascularCGRPnerve
fibresin theguinea-pigwas described in detail. Their findings indicate a substantial
CGRPnervesupplyto the heart and coronary bloodvessels. The carotid arteries
and thoracicaorta receive numerousCORP fibres, while the brachial and femoral
arteries10the limbscontain fewfibres. In the guinea-pigbrain, the cerebral arteries
were shown to be surrounded by a dense network of perivascular CGRP fibres,
whereas the small pial arteries were accompanied by few fibres. Vessels of the
respiratory and genitourinary trace received a moderate supply of CORP fibres.
In the gastrointestinal tract the mesenteric and gastroepiploicarteries had a dense
supplyof CORP-containingnervefibres. In contrast, small bloodvessels of skeletal
muscle received a veryscarce supplyof CORPfibres. Studiesin the rat have also
indicated a widespread distribution of CGRP-fibres in the cardiovascular system
(Mulderry et al., 1985). There are, however, some regional and speciesvariations
regarding the distribution of CGRP·immunoreactive nerve fibres (Wharton t t 01.,
1986).
The distribution of CG Rp· and SP-immunoreactivefibres isvery similar and
severalstudieshave nowdemonstrated thattheyarefrequentlyco- localized insensory
nerves (Lundberget aL, 1985; Uddman n aL, 1986; Wanaka et aL, 1986).
Neuropeptlde Y
Neuropeptide Y (NPY) :~ a36-amino acidpeptide isolated fromporcinebrain
tissue (Tatemoto et aL, 1982). The peptide has been sequenced (Tatemoto,1982)
and synthesizedbya solidphase method [Balasubrarnaniamet a L, 1987;Yamamoto
et al., 1984). NPYhas been found to be rich in tyrosine and is structurallysimilar
to pancreatic polypeptide (PP ) and peptide YY (PYY; Tatemot o et al., 1982). NPY
is widely distributed in the ce ntraland peripheral nervous systemsand has been
showntobe oneof the mostpotent vasoconstrictor peptidesisolatedso far (Emson
and DeQuidt, 1984).
In the perip' .ery, NPY has been localizedin perivascular nerve fibres of
several species,including man (Pemowet al., 1987). It isoften closely associated
with or co-storedwith noradr enaline (Ekblad et al., 1984). In the ra t, Allen and
co-workers (1985) have identified high concentrations of NPY th rougho ut the heart
and within the major bloodvessels,in particular inthe renaland superior mesenteric
arteries. This study showed a similar pattern of innervation by NPY· and NA·
containingnervefibres, which wasdepletedafter treatment with 6·hydroxydopamine
(6-0 HDA; Allenetal., 1985). In the guinea-pig, NPY-immunoreactivenervefibres
have beenfoundto be widely distributed in the vascular system (Udd man et al.,
1985) . In general,NPY fibres were more numerousaroundarteries than in veins
ofthe guinea-pig. The heart an d coronaryvessels,like the rat, were shownto have
a rich NPY-innervation. A well developed NPY plexus wasvisualized ar ound large
elastic andmuscular arteriessuc hasthe thoracic aortaand common carotidarteries.
Perivascular NPYfibres were numerous inarteriesofthe respiratory,gastrointestinal
and genitourinarytract s. Techniques of surgical and chemical sympathectomy, as
well as seque ntial immunohistochemical staining, revealed the coexistence of NPY
with NA hi perivascular nerve fibres of theguinea-pig (Uddman elaL, 1985).
Vasoactive Int estinal Polypeptide
Vasoactiveintestinalpolypeptide (VIP) is a 2S-aminoacid peptide which was
originally isolatedfrom porcine intestine andnamedforits potent vasodilatoryactions
(Said andMutt, 1970). VIP was fitst synthesized in 1973 (Bodanskyet a L)and has
since becomecommerciallyava ilable. This pep tide, which isstructurally related to
secretinandglucagon, wasoriginally thoughttobe limited to the ga strointe stinal tract.
However, rad ioimmunoassay a nd immunohistochemical studies have revealed that
VIP hasawidespread distributio n inthe body,localized in neurons (Fuxeet aI" 1977;
Larsson et aL, 1976).
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Perivascular ne rvefibres containingVL.~ -1!nmunoreacti\.ity jeve been found
mainly inregional vascular beds rather than in the large r eonducrng b loodvessels
(Whartonand Gulbenkian,198 7). In the cat.VIP-contail" i n ~ nerve fibres were found
to be numerous aro und arte ries of the uppe r respiratory, gastrointe stinal, and
genito urinary tracts (Uddman et tlLt 1981). V ery few fibres wer e found in blood
vesse ls of ske letal muscle and none were found in coronary art er ies. VIPfib res
were sparsearound largearteries and veinsand appeared tobe absente ntirety fr o m
blood vessels of the liver, sple e n end kidney. In the guinea-pig, similar results have
been reported (Della el 01., 1983). This study denc retrat eda spa rsesupplyof VIP·
immunoreact ive nerve fibres to IIIe heart and major d istributi ng arteries: ao rt a,
subclavian, car otid, femoral and pulmonary. orthe vascular beds receiving VIP
fibres, themost densely supplied arteria were the mesenteric a nd uterine arteries.
VIP innervation ofcerebralvesselsvaried from the most dense in thean terior and
midd le cereb ral arteries 10 ve ry lillie in tbe b a silar artery. As in the cal, arteries
runningtoskeletal muscleand majororganswere lessde nselysup plied.Throughoul
thebody 'Veins of the guinea-p ig were sparsely supplied with VIP nerve fibres.
E\'idence for th e coexistence of VIPwi th ACh has been summ arized by
Lundberg(1981). In addition it hasbeen shown that VIP .containing fibres were n OI
deple ted when noradrenergic nerves were degenerated by 6-0HDA or when SP
nerves were d isrupted by capsaicin(Dena tt at, 1983). Th issugge sts that VIPnerves
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innervating the vasculature form a populat ion distinct from substan ce P or
sympathetic nerves.
In summary. it can be seen th at the innervation of the vasculature is more
complexthan wascommonlyaccepted untilrecently. It nowappearstha t threetypes
of pe rivascular nerve plexusexist: the catecholamincrgic system which has NPYco-
localized with NAin nerveterminals, a system of peptidergic nerves containing SP
and CORP, and the system of cholinergicand VIP<ontaining nerve fibres.
1.1.2. Circulatingand Local Factors
There are many factors which contrib ute to the ove rall co ntrol of the
card iovascular system, some to a greater degree thanothers. In the circulation the re
are agents such as peptides and hormones which have a widespread influence on
vascular tone . Local factors such as flow, pH, Po, and P~ as well as the
concentrations of certain ions in the bl ood can determine the functional state of a
vescular beo.
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(a) Circulating Factors which Re gulate Blood Flow
Ther e arc certain naturally occurring vasoactive amlnes, peptides and lip ids
which circulate in the blood and can be grouped under the te rm local hormones or
autacoids. Among these are acetylcholineand carecholamines which maybefonned
ex traneuronallyand released into the blood. Acetylcholine has been shownto cause
relaxation of arteries,which is dependentupon the presence of intact endothelium
(F urchgott er aL, 1981). Utile effect has been observed in veins. Adrenaline,
secreted from the adrenal medulla, can cause vasoconstriction by its action on a-
adrenoceptocs or vasodilation by an actionon ,a-adrenoceptors of vascular smooth
muscle.
Histamineis one of the most potent of the endogenous biogenic emines. Its
actionson blood vessels are complicated, since it actson two receptor subtypesand
may alsointeract with the sympathetic nervous system(Brody, 1980). In a number
of species histamine has been shown to produce vasoconstriction mediated by H,
receptors, and vasodilation mediated byHzreceptors (Owen, 1977). Serotonin is
a vasoactive amine identified as S-hydroxytryptamine (S-HT). In the blood, S-HT
is contained in platelets and is involved in the clotting process. It is a potent
vasoconstrictor excepton blood vesselsof skeletal muscle and coronary vesselsof
the heart, which are dilated (Cohen et 01., 1981;Van Nueten et aL, 1984).
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Adenosine and its phosphorylated derivatives, AMP,ADP and AlP have
vasodilator activity in the vascular beds ofskeletal muscle and the coronary vessels
of the heart, and have thus been shown to pro duce a fall in blood pressure upon
intravenous injection. In many blood vessels ATP and ADP have been shown to
cause endothelium-dependent relaxations while relaxations to adenosine and AMP
were independentof the presenceofendothelialcells(van houtte and Rlmele, 1983;
reviewed by Furchgott, 1984).
Thepolypeptide familyofkinins includes substanceP, kallidinand bradykinin,
and angiotensin. Substance P has already been reviewed. The substances kallidin
and bradykinin are closely related pept ides of which bradykinin has been the most
studied. Bradykinin has been shown to have a potent vasodilatory action (Fox et
aI., 1961; Haddyet al., 1970). This is an endothelium-dependentaction which will
be discussed later. Studies have demonstrated that this actionis important in the
maintenance of normal blood pressure (Gavraset al, 1987). Kallidin is thought 10
have the same actionsand similar potency as bradykinin. Renin is an enzyme,
secreted by the kidneys, which activates the renin-angiotensinsystem to generate
angiotensin II. While angiotensin II is a direct vasoconstr ictor agent, it also elicits
the releaseof aldosterone from the adrenal cortex. Aldosterone regula tes sodium
and potassium excretion by the kidneysandthus contributes 10 the contra! ofarterial
blood pressure (Reviewed in Bowman and Rand, 1980).
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VasopressinIs a peptide hormone released from the neurohypophysis into
the circulation in response to nerve impulses. It is also known as antidiuretic
hormone (ADH). ADH is a potent vasoconstrictor of all types of blood vessel,
especially capillaries and venules. A major role played by ADH is in the response
to haemorrhage. Atrial natriuretic factor (ANF) is another peptide hormone
belonging to a recentlydiscoveredgroup of peptides (de Boldet al., 1981). ANF
isreleased Crom granulesin theatria ofmammals and has beenshownto be a potent
vasodilator in pre-contractedblood vessels(Currie et aL, 1983).
Prostaglandins are another group of local hormonesthat exert an effect at
or distal 10the site of.their synthesis(Vane and McGiff, 1975). Prostaglandins are
released from a varietyof tissuesincludingblood vessels themselves (Tuvemoand
Wide,1973). Prostaglandins havea wide variety of cardiovascular actions including
reduction of blood pressure,vasodilation of many vascularbeds and constrictionof
cerebral blood vessels.
(b) Local Factors Which Regulate Blood Flow
In additionto circulatingaminesand peptides in the blood,there are certain
local factors which may influence the circulation (Haddy and Scott, 1968). The
balance between dissolved oxygen (Ol) and carbon dioxide(COl) can have both
a direct and indirect effect on vasculartone. When levels are elevated,COl acts
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directly 10dilate bloodvessels anddep resscardiac function (Price.1960). Through
reflex actions, CO2 causes the release of adre naline from the adrenal medulla to
resul t in peripheral vasoconstriction and an increase in blood pressure. Similarly,
studies haveshown that a reduction in oxygen tension of the perfusing blood lowers
the resistance to flowin thecoronary. hindlimb,forelimb. lntestinel,gracilisandrenal
vascular beds (Berneet aL,1957;Daughertyet aL, 1967; Allinger et al., 1967; Skinner
and Powell, 1967).
The pH of blood is another factor involved in local regulation of flow.
Although the blood is a bufferedsolution, metabolic changes during exercise can
cause slight var iations in hydrogenion concentration. Studieshave shown that local
administration ofacid produceschangessimilar to thosewhichoccurduringincreased
COz tension. In fact some studies indicate that the action of COzis mediated via
the hydrogen ion(Hiltonand Eichholtz, 1925; McElroyeta/ ., 1958). It has thusbeen
shown that the hydrogen ion is a vasoactiveagent,with highconcentrations causing
dilation and low concentrations causing constriction.
Theconcentrationof potassium ion in the blood can also influence vascular
lone. II has long been known that a small increase in potassium in the blood or
in a perfusing solution causesvasodilation (Dawes,1941). It seems, however, tha t
the effect of potassium on the tone of vascular smooth muscle depends on its
concentration. Konold and co-workers (1968)founda vasodlletory response up to
a potassiumconcentrationofabout 35mM but at higher concentrations a contractile
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response was obtained. Vasoconstriction was also observed upon decreasing
potassium concentrationbelownormal (2.68 mM).
The dilator response ofconduitarteries10 an increase inbloodflowwas fir..t
observed in 1933 (Schretzenmayr, A: quoted by Pohlet aL, 1986). More recently
the vasodilatorresponse to increased flow has been shownto be mediated by the
e ndothelium (Pohl et al., 1986; Rubanyi et al, 1986 ). Bevan andJoyce (1988a) have
shown in rabbit ear artery that increased flow can cause contraction of a n intact
segment withor withoutthe presence ofendothelium. Inthe same preparation, they
have shown flow induced vasodilation afte r ac tive tone had been induced by
noradrenaline (Bevanand Joyce, 1988b).
Ma nyof the factorsinvolved in the control of vascular tone depend on or
are influenced by the endothelium. While this cell layer does act as a barrier
between the blood and vascular smooth muscle, it is also an active tissue involved
in the synthesis and release of compounds which act tocontract or dilate the blood
vessel.
17
1.2. The Endothelium
E nd otheli al cellsfonn a con tinuous layer a single cell thick tha t lines th e entire
circulatory system. These cellsact not only as a barrierbetween the blood and tile
vascular wall, but asanactivetissue receivinga varietyof signals,both blood-borne
and tissue-derived. Vasoactivecompounds interact with endothelial cells to cause
the release ofproslacyclin (CrutchleyetaL, 1983), platelet activatingfactor (McIn tyre
et aL, 198 5), endothelium-derived vasodila tors (re viewed by Furchgott, 1984) and
endothelium-derivedvasoconstrictingfactors (reviewedbyRubanyi, 1988). Thus, the
endothelium plays an important functional ro le in the control of cardiovascular tone.
1.2.1. Receptors on the Endothelium
A variety of receptors have been characte rized on the intimal enduthe lial
surface of blood vessels by the use of pharmacological techniques and
autoradiography. It isthroughthe mediation ofthese receptorsthat manyvasoactive
agentsact .
Severalstudieshave shownthat thepre sence ofa functionalendothelium limits
the vasoconstrictor response toadrenergic agonists suchasnoradrenaline(Cocks and
Angus, 1983; Miller and Vanhoutte, 1985; Angus el al., 1986). These authors
proposed that a-adrenergicagonistsstimulate therelease of anendothelium-derived
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relaxing(actor (EDRF) through an Clfreceptor located on the endothelial cell
surface. The vascular endothelium has also been shownto have p-adrenoceptors,
stimulationof which leads to elevation of cyclic AMP(Schafer et aL, 1980). These
p-receptorsaTC of the 132 subtype and do not mediate the release of EDRF when
stimulated (MacDonald a al , 1987).
The releaseof EDRF fromendothelial cells in response to ACh has been
shownto be mediated bya muscarinic receptoron the endothelium (Furchgott and
Zawadzki, 1980a). FurchgottandCherry(1984)couldfind no evidence to indicate
that this muscarinic receptor was of a novel subtype in their rabbit aortic ring
preparations. On the basis of affinity {or pirenzepine, a selective muscarinic
antagonist for the M, subtype,the muscarinic receptor of the endothelium which
mediatesvasodilation hasbeen classified asMz(Hyneset al , 1986,Chooel01., 1986).
However, more recently it has been suggested that two subtypesof muscarinic
receptor maybe responsible for the releaseof different typesof EDRF (Rubanyi
et at. 1987). Horst and colleagues have also suggested this possibility and have
indicatedthat further studieswith new and novel M2 antagonists may clarify the
situation(Horst e' 01., 1987).
Receptorsfor substance P havealsobeen localized on the intimalsurfaceof
bloodvessels. SubstanceP relaxed preparationsof preconstricted porcine coronary
artery onlywhen an intact endotheliumwas present, thus suggestingthe presence
of SP receptors on the endothelial cells (Gulatiel at., 1986). In dogcarotidartery,
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autoradiographic techniques have been used to demonstrate the presence of SP
receptors on the endothelium (Stephenson et aL, 1986).
The action of bradykinin in canine and human arteries has been shown to
depend on the presence of intact endothelium (Altura and Chand, 1981; Cherryet
01" 1982). These studies suggest that the vasodilatory effectof bradykininin these
vessel beds is the result of an interaction with some receptive substance of the
endothelium to elicit the release of EDRF.
Histamine recep tors have been studied in a variety of blood vessel
preparations. In rat thoracicaorta, H(receptors were found to be responsible for
mediating the release of EDRF in response to histamine (Van de Voorde and
Leusen,1983). RadioJigandbindingstudiesindicate a differential receptor population
betweenarteriesand veins. In guinea-pigaorta, HI-receptorswere found to bemore
concentrated on the endothelium than on the smooth muscle (Hideet al; 1988).
The population of H2:-receptors was foundto be of higher densityon the endothelium
invenules of mouse diaphragm than in arterioles or capillaries(Antohe et at, 1986).
Studies with ATP have indicated thai subtypesof receptors for purines exist
on the vascular endothelium. The P2"receptor which responds to the purine
nucleotides, ATP and ADP, bas been differentiated into 2subtypeson the basis of
affinityfor the antagonists,reactive blue 2 and a,,B-methylene-ATP (Houstonet a1.,
1987). These experiments indicate that it is the P2Ysubtypewhichis located on the
endothelium and is responsible for the releaseof EDRF elicited by ATP and ADP.
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Similarly,Hopwoodand Burnstock (1987)have found coronaryvasodilation to be
mediated by the P2y·purinoceptor subclass.
Althoughsome agents act directlyon thevascular smoothmuscle to elicittheir
response,it is evident that receptors on the intimal surfaceof the endotheliumplay
an active role in mediating vascular reactivity to a wide variety of vasoactive
substances.
1.22. Endothelium-Derived RelaxingFactor
It was first discovered in 1980 tha t an intact endo thelium was required (or
the relaxation of isolated arteries to occur in response 10 ACh (Furchgott and
Zawadzki, 19808,1980b;Furchgott et al , 1981). This findingexplained whyACh,
a potent vasodilator of arteries in vivo. often produced no relaxation or even
contractionof isolated preparations of arteries in vitro (Furchgcn, 1981; Furchgott,
1982). In those tissues whichfailed to respond to ACh, the endotheliumwasoften
damagedorstripped from the vesselwallduring preparation. In their originalreport
of these findings, Furchgott and Zawadzki(198Oa) proposed thai ACh was acting
on a muscarinic receptor on the endothelium10 stimulate Ihe release of one or more
factors which causedrelaxation of vascular smoothmuscle. The term endothelium-
derived relaxing faclor(s) (EDRF) was coined for this substance(s) (Cherryet aL,
1982).
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(a) Characterization and Identificationof EDRF
These original findings by Furchgott and Zawadzki prompted many
investigations into the identity and mode of action of EDRF. Early studies
demonstrated the lack of effect of cyclooxygenase inhibitors on the relaxingaction
of ACh indicating that EDRF was not a prostaglandin (Furchgott and Zawadzki,
198Oa). EDRF is a labile {actor with measured half lives of 6 to 49 seco nds (G riffith
et aL, 1984;Ferstermann et 01., 1984; Rubanyiet 01.,1985; Angusand Cocks, 1987).
Like the nitrovasodilators, such as nitroglycerin and sodium nitroprusside (SNP),
EDRF has been shownto causevasodilation bystimulation of the soluble guanylate
cyclase of vascular smooth muscle, resulting in elevated cyclic GMP levels
(Fcrstermann et al., 1986; Holtzmann, 1982; Ignarro et 01., 1984; Rapoport and
Murad,1983a). CyclicGMP then mediatesrelaxation, probablyby multipleactions
on the control of intracellular free calcium (Collins el al., 1%6). EDRF and the
nitrovasodilators also inhibitplatelet aggregation (Ayumael aL,1986),presumably
via a similarcyclicGMP-mt:diated action.
In the search for the identityof EDRF, several agentsand conditions which
inhibitendothelium-dependent relaxations were found. It was discovered that the
actionsof EDRFonvascular smoothmuscle are potentiated bysuperoxidedismutase
andcytochromeC (Gryglewskiet01.• 19800; RubanyiandVanhoutte, 1986; Moncada
et aL, 1986)and are inhibited by FeZ" (Gryglewski et al, 1986b), hydroquinone
22
(Griffith et aL, 1984;Moncada tt at.. J986) and by pyrogallol (Moncada t l at,
1986). This led to the scgges-ion that these agents inactivate EDRF via the
generation of superoxidcanions (Moncadaet aL, 1986). Haemoglobin also inhibits
the actionsof EDRF (Griffithd oL, 1984; Martin tl QL, 1985) probablythrough a
different mechanism of action involving the bindingof the molecule (Cocks and
Angus., 1985; Martin et aL, 1986).
Finally, as the act ions of EDRF were found to be quite similar to those of
the nitrovasodilators, it was suggested by Furchgott (1988) that EDRF might f>imply
be nitric oxide (NO). Nitric oxide is thought to be the active metabolite througe
which nitrovasodilatcrs stimulate soluble guanylate cyclase.Evidence hasbeen given
by Palmer, Ferr ige, and Moncada(1987)to show that NO released fromendothelial
cells is indistinguishable from EDRF in terms of biologicalaClivityand stability, as
well as susceptibility to inhibitionby haemoglobin and enhancementbysuperoxide
demutase. Sincethis first report. further contirmation that EDRF is NO has been
providedbystudiesof the comparativepharmacologyof the two agents{Hutchinson
et al, 1987; Radomski a at.,1987}. Mechanisms other than the release of NO may
also play a role in endothelium-dependent relaxation. Mechanisms have been
suggested including mediators such as ammonia {~~H3 : Vanhoutte, 1987aj, or the
involvement of ion channels which may regulate EDRF release or propagate
endothelial signalsvia gap junctions (Olesen el al, 1988; Lansman et al, 1987).
An endothelium-dependent transient hyperpolarization of vascular smooth mwcle
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cells,which maybe independent ofNO,basalso beensuggested(Vanhoutte, 1987a).
These observations must be fullyinvestigated before it is known if non-prostanoid
endothelium-dependent mediators other than NO exist.
(b) Agents thai Produce Endothelium-Dependent Relaxation
Although acetylcholine was the first agent shown to elicit endothelium.
dependentvasodilation, a varietyof agents, beth humoral and synthetic, have also
been shown to cause the release of EDRF. Some of these agents also cause the
release of prostaglandins {rom endothelial cells. However, prostaglandins do not
appear to have a significant ro le as media tors of these relaxing effects. In addition,
withsomeof these agents,endothelium-dependentrelaxationof isolatedarterieshas
been limited to certain species. In scme cases it is limited to specific arteries in a
particular species.
Acetylcholine was first shownto causerelaxations which were dependent on
the presenceof intact endothelium in isolated ringsof rabbit thoracic aorta using
isometric tension measurements (Furcbgott, 1981; Furcbgou and Zawadzki, 198Oa,
1980b; Furchgoltet 01. , 1981). In addition to the actions of ACh on rabbit aorta,
itwasfound that ACh causedendothelium-dependent relaxationsin isolated arteries
from all mammalian species. These tissuesincluded: rabbit superior mesenteric.
pulmonary,and eararteries;rat thoracicaorta; guinea-pigthoracic aorta; cat thoracic
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and abdominal aortae, superior mesenteric, pulmonary, and ex ternal iliacarteries;
and dog circumflexand left anterior descending coronal)' arteries (Furchgott and
Zawadzki,1980a). Other investigatorshavefound relaxations to AChin canine renal
(Chand and Altura, 1981) and femoral arteries (De Mey and Vanhoulte, 1981), rat
(Daviesand Williams, 1984) and pig aorta (Gordon and Martin. 1983), as wellas
cat cerebral arteries (Lee, 1981) and bovine coronaryarteries (Holtzmann, 1982).
Studies on human blood vessels have shown that ACh causes relaxations in the
presenceof intact endotheliumin isolatedrenaland peripheral arterial rings(Luscher
et al., 1987a) and in isolated renal, splenic; gastric,pulmonary,brachial, transverse
cervical and coronary arterial rings (Them et aL,1985). The endot helium-dependent
vasodilatory effectof ACh is much lesspronounced in isolated venouspreparations
(De Meyand Vanhoutte, 1982).
A synthetic compound, the calciumionophore A23187 is even more potent
than AChin itsendothelium-dependentvasodilatoryactions (Zawadzkia at, 1980).
Against highlevelsof tone, the maximal relaxation byA23187isalways greater than
that byACh(Furchgottetal, 1983). An187 has been shownto cause endothelium-
dependent relaxations in rabbitthoracicaorta (Furchgou,1981; ZawadzkietaL, 1980;
Singerand Peach, 1982), rat thoracicaorta (Rapoport andMurad, 1983b), pig aorta
(Gordon and Martin, 1983) and in a variety of human arteries (Thornet at, 1985;
Thornet al., 1987a). It is interesting to note that in the presence of a maximally
effective concentration of A23IS7, additions of ACh and other endothelium-
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dependent vasodilators produce no relaxationof contracted arteries (Furchgon tt
at, 1983). This besbeen attributed to A23181 fully activating the mechanism (or
production and release of EDRF in endothelial cells.
Noradrenalineand selective Ql-8c"renoceptor agonists can cause relaxation of
canine and porcine coronary and systemic arteries and canine pulmonary arteries
and veins if the endothelium is present (Cocks ana Angus, 1983; Miller and
vanhoutre, 1984). In the canine coronary artery the relaxing effects of the p.
adrenergicagonists, noradrenaline and isoproterenol are reduced following removal
of the endothelium(Rubanyiand vanhcune , 1985a). It is not certain whether this
greater effect is due to an action on s-receptorson the endothelium or if relaxation
is caused by the basal release of EDRF. The presence of Q2-inhibitory receptors
on the endotheliumdoeshelp 10explainwhy the contractile response to nonselective
c-adrenocepror agonists is enhanced upon removal of the endothelium.
The purines ATPand ADP,whichare released byplateletsduringaggregation,
also induceendothelium-dependent relaxations in arteries. Removalof endolhelial
cellswasshown to markedly reducethe gradedconcentr:".tion-dependent relaxations
to ATP or ADP in isolated preparationsof rabbit aorta (Furchgcu, 1981; Furchgott
et al., 1983; Furchgolt and Zawadzki, 198Oc), dog femoral artery (De Mey and
Vanhoutte, 1981) and pig aorta (Gordon and Martin, 1983). Vasodilation by
adenosine and AMP in rabbit aorta and dog femoral artery were shown 10 be
independent of the presence of endothelial cells (De Mey and v anbouue, 1981;
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Furchgott el af., 1983;Furchgott and Zawadzki, 198Oc). However, in pig aorta a
significant pari of the relaxation by adenosine and AMP has been reported to be
endothelium-dependent (Gordon and Martin, 1983). Relaxations to adenosine in
canine coronary artery arc also mediated by the endothelium (Rubanyi and
Vanhoutte, 1985a).
SubstanceP is one of the most potent endothelium-dependent vasodilators
studied (Zawadzki er aL, 1981). SP has been shown, using an electromagnetic
flowmeter technique, to increaseblood flowin the aorta, carotid,hepatic, superior
mesenteric, and femoral arteries of the dog (Hallberg and Pemow, 1975).
SubsequentlySPhasbeenshowntogiveendothelium-dependentrelaxation inisolated
rings of rabbit aorta and dog superior mesenteric arteries which had been
preconstricted with noradrenaline (Furchgott et al. 1983). The threshold
concentrationfor relaxation by SP was 10 pM in rabbit aorta and I pM in dog
superior mesenteric artery. In these experiments a desensitization to SP at I nM
occurredwithin10minutes. This wasovercomebywashoutof the preparation and
did n01have anyeffect on relaxation 10 ACh or A23IS7. Endothelium-dependent
vasodilationbySPhas alsobeen studiedin isolated dog (D'Orleans-Juste et al, 1985)
and pig (Gelati e! aL, 1987) coronary arteries. In the dog, SP relaxed isolated
coronary arterial rings whichhad been preconstricted withnoradrenaline (20 nM)
at a threshold concentration of 65 pM. In isolated ringsof pig coronary artery;
which, like human coronaryartery,contracts to acetylcholine (50 JIM), the threshold
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for endothelium-dependent relaxation to SPwas 30pM. Substance P has alsobeen
shownto cause vasodilation upon intravenous administration in the preconstricted
pulmonary vasculature of the dog (Archer et aL, 1986). In humans, SP has been
shown to Increase blood now in the skin and skeletal muscle of the fore ann upon
close arterial infusionof 1·2 ng/mimne (Eklund et al, 1977). Experiments on isolated
branches of human mesenteric arteries haveshownthat relaxations bySP are strictly
dependent on the presence of endothelial cells (Furchgolt et aI., 1983).
Bradykininis alsoknownas a potentvasodilator. Bradykinin has been shown
to produce concentration-dependent relaxation of canine intrapulmonary and renal
arteries which is dependent on the presenceof an intact endothelium (Altura and
Chand, 1981). Removal of the endotheliumresultedin eithera contractile response
to bradykinin or no response at all. In isolated rings of dog carotid arteries
preconstrictedwithnoradrenaline (20nM),bradykininelicitsconcentration-dependent
relaxationsat a thresholdconcentrationof2n M (D'Orjeans-Juste eral.,1985). These
relaxations occurred only in the presence of an intact endothelium. The lack of
inhibition of this vasodilatory response to bradykinin by cyclooxygenase and
llpoxygenase inhibitors indicated that it was not mediated by prostaglandins. An
extensivestudybyCherryand co-workers (1982) evaluated the actionsof bradykinin
in isolatedarterial rings from cats, dogs and rabbits. In the superior mesentericand
celiacarteries from rabbit and cat removal of endothelialcellsdid not consistently
result in loss of the relaxations to bradykinin. This relaxation was blocked by
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cyclooxygenase inhibitors and thus in these vesselsthe actionof bradykinin Bppean;
to be mediatedby prostaglandins. In contrast, all arteries tested from the dog:
splenic,gastric, celiac,femoral, renal,coronary.pulmonary, and superior mesenteric,
showed a requirement for endothelial cells in the relaxation by bradykinin.
Cyclooxygenase inhibitors did not interfere with the re laxation res ponse and 50
bradykinin is thoughtto act via EDRF in bloodvessels of the dog. Bradykininwas
alsostudied on ringsof mesentericarteryfromhumansand found 10 elicitrelaxations
with similar mechanism to those in dog arteries . In addition, Go rdon and Martin
(1983) have reporte d that bradykinin induces relaxations of pig aorta which are also
endothelium-dependent and prostaglandin-independent.
Vasoactive intestinal polypeptideisa potentvasodilatorwhichacts bydifferent
mechanisms in a varietyof species. In rat aorta VIP causedrelaxationswhichwere
endothelium-dependent (Davies and Williams, 1984). In a study of human blood
vessels, VIP producedendothelium-dependent relaxation in coeliacbranch arteries,
but ill isolated pulmonaryarteries its relaxing effect wasindependent of the presence
of endothelial cells (Thorn el aJ., 1987a). Another group has also reported an
endothelium-independentmechanism for relaxation of human pulmonary arteries by
VIP (Barnes et aJ., 1986). VIP has also been shownto relax human gastric and
transversecervicalarteriesinan endothelium-dependentmatter (Thom et aJ., 1987a).
The vasodilationof bovinepulmonaryartery andcaninecoronaryartery hasalsobeen
reported to be independent of the presenceof endothelial cells(Griffith eraJ., 1985).
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Calcitonin gene-related peptide is another peptide which has vasodilator
act ivity in man and other mammals. In a strip prepara tion of ra t thorac ic aorta
CORP gavedose-dependent relaxationsof noradrenaline-inducedconewhich were
dependent on the presence of endothelial cells (Brain ~t aL, 1985). This relaxation
was partiallysuppressedbycyclooxygenase inhib!10n and so prostaglandinsmaybe
responsible for some of the response to CGRP. In this study CG RP also caused
vasodilat ion of the cutaneous microvasculature of rabbit and man in vitro. CGRP
was 1000 timesmorepotent than ACh, ATP, ADP, adenosine, S-HT and SP in this
action. Another studyhas confirmed endothelium-dependentrelaxations to CGRP
in ringsof rat thoracic aorta (Kubotat t aL.1985). RecentlyCGRP has been shown
to relax preconstricted segments of human radial, coronary. gastric and cerebral
arteries inan endothelium-dependent manner (Thorn tt aL, 1987b). Cyclooxygenase
inhibitors did not block the responses to CGRP and thus EDRF is thought10 be
the mediator of these relaxations.
Histamineis a vasodilator whichhas been shownto act via EDRF in certain
isolated blood vessel preparations. It was fint demonstrated to cause a dose-
dependent relaxation in ringsof rat thoracicaorta, precontractedwith noradren-
aline (Van de Voordeand Leusen, 1983). This relaxation to histamine (10-1000IJM)
was dependent on the presence of an intact endothelium and was not mediated by
prostaglandins. The use of specific histamine receptor antagonists Indicated that
histamine was actingon an H, receptor of the endothelium. Rapoport and Murad
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(1983) have reported similar results for histamine in rat aorta . Histamine also
produces endothclium-dependent relaxationof guinea-pig pulmonaryartery (Salah
and Inui, 1984). This response is thought to involve the H, receptor on the
endothelium in this tissue as well. It is alsoof interest to note that histamine causes
the release of EDRF from human umbilical blood vessels via an H, receptor subtype
(Van de Voorde et aL,1987). This is a tissue which does not release EDRF in
response to ACb.
Thrombin, whichis generated during the cascade reactions of coagulation,
causes endothelium-dependent relaxation in basilar, coronary, femoral, saphenous,
splenic, and pulmonary arteries of the dog (De Mey et aL, 1982; De Mey and
Vanhoutte, 1982;Katuslcel aL, 1984) and in aorta of the rat (Rapoport et 01.,1984).
Relaxation was not inhibited by inhibitors of cycJooxygenase and prostacyclin
synthetase, but was inhibited by heparin. Similar findings have been made on
thrombin-Induced endcthellum-dependent relaxation of isolated canine coronal')'
arteries (Ku, 1982), In these arteries, the relar.ation to each addition of thrombin
was transient, and was counte racted by a direct contract ile action on the smooth
muscle.
Platelet activating factor (PAF) is released during platelet aggregation and
has been shown to cause vasodilation in a number of animal models (Vargaftig and
Benveniste, 1983). At veryhighconcentrations, PAP induces endothelium-dependent
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relaxations in isolatedcanine coronaryand femoral arteriesand rat aortae (Kamitani
et al., 1984; Kasuyaet aL, 1984).
Serotonin is also released duringplatelet aggregation. Precontracted canine
coronary arterieshave been foundto relax to serotonin onlyif endothelial cellsare
present (Cohen et al., 1983). In the absence of endothelium, serotonin produces
only a contraction in the caninecoronaryarterial rings. Endothelium-dependent
relaxationby serotoninhas nor been reported for any other arteries.
Hydralazine is an antihypertensivedrug whichproducesits relaxant effecton
isolated ringsofrabbitaorta mainly throughanendothelial cell-dependentmechanism
(Spokaset 01., 1983). This effect occursat relativelylowconcentrations of O.1-1I£M.
This is of interest because most other antihypertensive drugs; nitroglycerin,
nitroprusside, minoxidil and dtazoxtde, are thought to act directly on the vascular
smooth muscle,independent of the presenceof endothelial cells.
Endothelium-derivedrelaxing factor is alsoreleased fromarteriesin response
to increments in flow (Holtz et at., 1984a). Effluent from perfusedrabbit aorta
(Griffith et at., 1984), or canine femoral artery preparations with endothelium
(Rubanyiet al., 1986), in response to increasedflow, caused relaxations of bioassay
coronaryarterieswithout endothelium. Increments in flow througharteries in \'ivo
(Gerovaet al., 1983; Hintz and Vatner, 1983; Holtz et aI., 1984a; Kaiseret al , 1985;
Rubanyietal, 1986)or in vitro (Holtzeral, 1984b)inducevasodilation,whichcannot
be prevented bycyclooxygenase inhibitors (Holtzet al, 1984a),but can be abolished
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byremovalof the endothelium(Holtzet aL,1984b)or depressed by methylene blue
(Kaiser eraL,1985). Thus, the EDRF released by large arteries in response to flow
has characteristicsvery similarto that released by ACh.
It is evident that a wide range of agents cause the release of a relaxing
substance from the endothelium. Some of these agents arc found in perivascular
nerve fibresand some are endogenousto the circulation undervariousconditions,
while somecompounds which elicit the release of EDRF are synthetic. It seems
that even the flow rate of blood through the vasculature is involved in the control
of smooth muscle tone through the mediation of the endothelium. Whether all
these agents release nitricoxide or other types of a non-prostanoid EDRF is not
known. However,based on commonsusceptibilities to inhibitoryagentsit is likely
that manyof these agents act to releasethe same relaxing factorthat ACh produces
(Furchgotlel al., 1983; Furchgou, 1984).
1.2.3. Endothelium-Derived CcntraetingFactor
In addition to the vasodilator substances which are released by the
endothelium, evidencehasbeen given for the releaseof one or more vasacontractile
factors fromvascularendothelial cells, It wasfirst repon ed in 1982 that an intact
endothelium was necessaryfar contraction ofcanine systemic and pulmonaryveins
in response to arachidonicacid (De Mey and Vanhoutte, 1982). Vasoconstriction,
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dependenton or enhanced by an intactendothelium. hasbeenobserved in response
to various chemical and physical stimuli (reviewed by Vanhoutte,1987b; Vanhoutte
and Katusic, 1988).
(a) Characterization and Identificationof EDCF
Partof the evidence supportingthe release otvasoconstrictcrsubstances from
the endothelium comes from experiments in which anoxiaproduced endothelium-
dependent contractionsof peripheral, coronary, and cerebralarteries(Rubanyi and
Vanhoutte, 1985b; De Mey and Vanhoutte, 1983; Katu sic and veuh outte , 1986).
These responses were not sensitive to inhibition of cyclooxygenase and thus were
attributedto an unidentified vasoconstrictor substance termedEDCF1 (Vanhoutte
1987b). It has also been demonstrated that cultured endothelialcellsproduce a
vasoconstrictor peptide (HickeyttaL, 1985; Gillespieet al; 1986), which has recently
been characterizedand namedendothelin (Yanagisawa et aL,1988). Endothelinhas,
upon further study,been shownto consist of a group of three structurally distinct
isopeptideswhich have different pharmacological profiles(Inoue etal., 1989). Since
the production of endothelin and its contractile effect do not depend on cycle-
oxygenascactivity, it has been proposed that EDCF, maybe endothelin. There is,
however, evidence to indicate thatendothelin is unlikely to be the mediatorof the
so-caned hypoxic response ofvascular smooth muscle(Vanhoutteand Katusic, 1988).
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Another series of experiments has led to the discovery of endothel ium-
dependent contractions thai are sensitive to inhibit ors of cyclooxygenasc. These
studies bega n with the find ings of De Mey and v enhouue ( 1982) that arac hidonic
add caused an endothelium-dependent augmentation of noradrenaline-induced
contraction in systemand pulmonary veinsof the dog. Further studies revealed
endothelium-dependent contractionsin canine veins and cerebral arteriesand in the
aortaof spontaneouslyhypertensive rats to a varietyofstimuli,includingarachidonic
acid, acetylcholine, A23187, serotonin and sudden stretch (Miller and Vanhoutte,
19853; Luscher and Vanbouue, 1986a; Luscher and Vanhounc, 1986b; Katusic et
01., 1987; Katusic it aL, 1988). The mediator of these endothelium-dependent
contractions was suggested 10 be an unidentified product of the cyclooxygenase
pathway, possible thromboxane Az. and was tentatively referred 10 as EDCF2
(Vanhouuc, l987b). Vanhoutte and Katusichavenoted tha t supercdde anicncauses
contractions in canine basilar artery and that superoxide dismutase plus catalase
abolish enJothelium-dependent contractions to A23181 in the same preparation
(Vanhoutte and Katusic, 1988). On the basis or this and other studies with
cyclooxygenase (Kontos et aL, 1985; Rosenblum, 1982) it has been suggested that
EDCFz is the superoxidean ion(v anhouue and Katuslc, 1988).
Thus, it can be seen that the endothelium can be responsible for mediating
both vasodilation Ihrough the release or nitric oxide and possibleother dilator
substances. and vasoeonstrictcn through the release or endothelin peptides,
lS
thromboxane Az. superoxide anion andpossibleadditionalvasoconstrictorsubstances.
Thephysiological significanceof these processesis beginning tobe understood and
the endothelium is now r ecognized asan impona nt ccmributor to the con trol of
vascular tone.
This review has attempted to encompass the wide number of components
involved in the control of the cardiovascular system. From the direct control of
vascular and cardiac muscle provided by the autonomic nervous system, 10 the
influence of factors in the circulation, the rate of flowof blooddependson the cnd
result of a balance between vascular contraction and relaxation. Although much
progresshas been made towardan understanding of the mechanisms involved inthis
control, much remainsto be studied with respect to cardiovascular control in disease
stales such as atherosclerosis.diabetes and hypcn ension.
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1.3. Objectives of the Study and Review of Methods
The objective of this study w as to tes t the hypothesis that th e ability of
vascularendotheliumto release EDRF inresponse10stimulation byvasoactive agents
is rel ated in some way to the pattern of perivascular innervatio n. From thiswor k
it is hoped to determinewha t influence,if any, the perivascular innervationof a
vascularresistance bed hasup on the ability of endothelial cells to cause relaxation
of m edial smooth mu scle. In disease states such as hypertension and diabetes,
changesoccur inthe structure and functionof the vasculature(Sco ttand Pang,1983;
Brody el al., 1980; Gabbay, 1911; McMillan, 1975). Information about the
mecha nisms involved in the control of the vasculature may be utilized in the
development of pharmacologi cal agt.-tts used to treat cardiovasculardisease.
1.3.1. The McGregor-Prepara tion
The tissuechosen for this study was the McGregor prepar-ati onof the isolated
perfused mesenteric art erial bed of the rat (McGregor, 1965). There a re sever-al
reasons for this choice. First, an isolated tissue was chosenso that cardiovascular
reflex mechanismsdid notcon tribute to themeasured result. Some whole animal
preparations have been usedto investigate the effects of vasoactive agents onblood
flow ofvascular beds, but these resultscanbecomplicated byregulatoryme chanisms
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insitu (Hallbergand Pemow, 1975; Smiesko et QL, 1985; Angus et aL, 1983; Archer
el a l., 1986). Second, an intact arte rial resistance be d was studied in order to
simulate the in vivo situation in the determination of the effect of the vasoactive
agents used. While there are problems inherent in the setting up and maintaining
of a n isolated vascular bed, th is tissu e is a comparati velysimple preparation of
perfused mesenteric blood ve ssels. The majority 'If the stud ies of en dothelium-
dependent relaxation have been carried out o n isolate d ring o r strip pre parati ons
of lar ge conduit arteries (Furchgou a nd Zawadzki, 19808; reviewedby Furchgott,
1984). Allhougnthese preparations are easily set upand respond well to vasoactive
agents,theentiretissue isbathed inth e administered dr ugsolutions. In the isolated
perfusedmesenteric arterial bed, only the intimal surface of the blood vessel is
exposed to administered agen ts. tn addition, the role of the Conduitar teryin the
contribution toblood pressure isthought tobe lessimportanttha n th£lt of thesmaller
resistancevessels of the vascu lar beds (Prewitt etaL, 1987; Longhurst el al.,1986).
Ring andhelicalstrip prepara tions of resistance blood vessels. including superior
mesenteric artery,have also been studied (Toda, 1974; Furcbgou and Zawadzki.
198Oa;reviewedbyFu rchgott, 1984). However, thesmallerdiame terof thesevessels
makes il difficult to avoidendo thelial damage d uring preparation. These tissues are
also completelybathed in the agent being tested.
The choice of the mes enteric bedof the rat was based on the body of
anatomical and histological in forma tio n already available in th is labora tory(SCali,
38
Robinson and Foote, 1986, 1989). There is also extensive information in the
titc rn.tureabout nutrition, endocrino logy , metabolis m,an d physio logyof the ratwhich,
alon g with its size,make it a usefulanimal for c:ardiovascularre search ( reviewed by
Gill et aL, 1989~
The McGregor preparation of the isola ted perfusedmesenteric ancrial bed
is, th erefore, a suitab le tissue in which to stud- 'be acti on of vasoactive agents on
the en dotheliumin a vascular resistance bed. However, inan isolated vascular bed
such as this, there are many components which react to vasoa ctive subs tances 10
contribute to the overall measured changes in perfusion pressure. It is possible
that in pharma rological experi ments wi th Ihis tissue the variatio n in measurements
may be high.
1.3.2. lmmunohinochemistry
Thepe rivascular iMc:rv a lionof the mesenteric art erieswas visua lizedusing
immunohistochemical staining 10 verify the p resence or absence of nerve fib res
containing SP ornt Th e method of im munohistochemicalstaini ngwasa threestep
peroxidase ann-peroxidase (P AP) pro cedure which utilizes diaminoben zidine to
produce a colored reac tion pro ductwh ich can be viewe d at a later date with light
microscopy.Thismethod hasbeen rout inelyused inthis laboratory (Scott, Robinson,
and F oote, 1987) and is quite specific for the neuropeptides being visualized.
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Although primary and linking antibodies a re readily available for th is method of
staining. these materials can be expensive. II was also possible to do
immunoh istochemical stain ing using primary antibodies which are linked to a
fluorescent marker. This method is alsospecflc for the neuropeptid es but is more
expensive and the tissues must be viewed immediately as the fluor escence may
fade.
1.3.3. Electron Microscopy
Transmission electron microscopy was utilizedto check the integrity of the
endothe lial lining of the blood vessels of the tissue preparations. This typ e of
electron microscopy allowedus to visualizea crosssection of even the smallest of
the jejuna l arteries. While each ] pm sect ion is only a very small sample of the
vessel bed, a large number of samples were taken randomly. In this way it was
possible to determine if endothelial cellswere being removed from any...essels in
the preparation. There are other methods for viewingthe endothelial surface of
blood vessels. Scanning electron microscopy can also be used to check the
endothelium. As well,a method of ell face sil...er stainingallowsvisualization of the
endotheliumby light microscopy (Poole et aJ., 1958). Neither of these methods is
suitable for the smalljejunal vessels of the mesenteric bed as the ve ssels m ust be
cut lengthwisc to visualize the intimal surface.
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1.3 .4. Methodsof Chemical Denerva uoa
6-Hy<hmydopanilile
Development of the sympathetic nervoussystemwas prevented ina gr oup
of ratsfor this study byneonataladministrat ionof&-hydroxydopamine (6-0HDA~
an isomer o f norad renaline . This treatme nt was use d to pro vide an experimental
model of bloodvess elswith an alter ed sympa thetic nerve fibr e plexus .
In 1959, wh ile studying the enzymatic conversions of d opamine to
no r adrenaline in ra t tissue homogenates, Senoh and co-workers di scovered and
isola ted the metabo lite,6-0 HDA Th e initial biological effects of 6-0 HDA were
reported shortly thereafte r (Porte r et 01., 1963; Porter et at., 1965;Ston e elaL, 1963;
Sto ne et 0/ ., 1964). These esperimeou demonstrated that 6-0HD A produced
dep letionof noradre naline in the hearts of m ice and d ogsand that this effect lasted
longer than that caused byother agents. It was alsofound that certain otheragents
could antago nizethe effectof 6-0HDA, indicatingthat uptakeint o thencradrencr gic
neu ronwas necessary for this action of (}.OHDA. Next came the disco verythat 6-
OH DA caused an actual de struction of the terminal endings of the sympathetic
neurons(Tranzer an d Thcenen, 1967, quoted by Kostrzewa an d Jacobowitz.1974).
This result was later defined as "chemical sympathectomy" (Tr anaerand Thoenen,
1968) . Since these origina l findings, a vas t amou nt of information has been
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accumulated on 6-0HDA and its pharmacology. For detailed reviews the reader
is referred to Thoenen and Tranzer (1973) 35 well as Kostrzewa and Jacobowitz
(1974).
The sequenceofeventswhichlead10 the destructionof noradrenergicfibres
after administration of 6-0HDA has been well described, beginning with the active
uptake into sympathetic neurons. 6-0HDA is actively transportedto inteaneuronal
sites where it acts as a false transmitter, displacing noradrenaline (Thoene n and
Tranter, 1968). When critical inteaneurona l concentrations of &.OHDA or
met abolites are attained, destructive processes begin and cellular enzymes and
elementsof therespiratory electron transport chainare destroyed. It is at thispoint
tha t thesympatheticnerve terminals lose their abilityto conduct action potentials
but maystill havea relatively intactmonoamine uptakemechanism (Haeusler, 1971).
Because of the internal destruction, noradrenaline is released into the synapse,
resulting in a host of sympathomimetic effects (Stoneet aL,1%4). After a period
of time,the nerveterminals maybe completelydestroyedand there will be a marked
reduction of noradrenaline, tyrosine hydroxylase activity, and monoamine uptake
capacityin these tissues(Iversenand Uretsky, 1970).
The action of 6-0HDA is selective for terminal fibres of noradrenergic
sympatheticnerves. Blecucnmicroscopic studies haveindicated that cholinergicand
noradrenergic neurons,myelinated axons, smooth musclecells,Schwann cells and
endothelial cellsappear normalwhile noradrenergic neurons are in the processof
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degeneration (Bloomtt aL, 1969; Tranzer and Thoeeen, 1967, 1968). However, it
wasdiscovered that after a period ofweeks the adrenergicterminalplexusappeared
to regenerate in tissues in which the NA content had been markedly reduced by 6-
OHDA treatment (Thoenen and Tranze r, 1968). Thus, while destruct ion of
noradre nergic terminals had been achieved. the perikarya appeared intact to bring
about the regeneration of fibres. This reversibility was found to be related 10 the
age of the animals at the time of 6-0HDA treatment. When 6-0HDA is
administered to newborn animals its neuro toxic effectsarc accentuated, Angelett i
and Levi-Montalcini (1970) found that when~HDA was given to newborn mice
or rats it caused extensive lesions, resulting in the destruction of the sympathetic
perikarya in the superior cervical, stellate, celiac, mesenteric gangliaand all of the
thoracic paravertebral chain. Thus thedistinction wasmade betweenthe "reversible
chemical sympathectomy" in adult animals and the "irreversible chemical
sympathectomy"in newbornanimals after treatment with6-OHDA(Thoenen, 1971).
Wlu1e6-0HDA has proven to be a valuable pharmacological tool, there has
been some controversyas to its usefulness in cardiovascular research. Some studies
indicate that 6-0HDA does not produce a complete sympathectomy of the
vasculature (Berkowitzn al., 1972; Finch et al., 1973a,1973b; Kurnjek et al., 1984).
However, the degree of chemical sympathectomy attained depends upon a variety
of factors. While the age at which treatment is initiated is clearly important, the
dose of 6-OHDA, its route and frequency of administration, as well as the tissue
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being exa mined are all important factors whi ch contribute to the effectiveness of 6-
OHDA tr eatment.
Capsaicin
Capsaicin treatmentwasused in this studyto destroy peptidergic peripheral
innervationcontainingthe peptidesSPand CGRP. This treatment produceda group
of rats with an alteredpeptidergic nerve fibre plexus.
Capsaicin is thetrivialname for 8-methyl·N-vanillyl~nonenamide. the major
pungent componentof hot peppersof the genus Capsicum. Hot peppershave been
used as food eddltives and preservatives, as medicines and in social ritua ls for
centuries. In the late 1940's an extensive characterization of the pharmacological
effects of capsaicin and its congeners on sensory processes in mamma ls was
undertaken byJancso and colleagues in H ungary. Thesestudiesrevealedthat most
of thebiological effects of capsaicin result froman initial intenseexcitationof certain
sensoryneurons, followed bya prolonged period of insensitivity to physicochemical
stimuli. For reviews of this early research on capsaicin the reader is referr ed to
Jancso (1968), Virusand Gebhart (1979) and Szolcsanyi (1982).
The observation that capsaicindep letes fluoride-resistant acid phosphatase
activity, known to be associated withcentral terminalsof some primary afferent
neurons fromthe dorsalhorn of the spinal cord, suggested that capsaicin acts on
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the biochemicalprocessesof thesesensoryneurons(Jancsc and Knyihar, 1975). This
had beensuggested earlierby Gasparovicand co-workers(1964)whodiscovered that
capsaicin tre atment reduced the amount of b ioassayable SP in thespinal cord but
not in the brain. Fu rther confirmation of the specificity of the effects of capsa icin
for SP-containing primaryafferent neurons came from the results of Jessel and co-
workers (1978). They observed that systemic treatment of adult rats with a
cumulative dose of capsaicin depleted SPfro m the dorsalhorn of the spinal cord
withoutage neraleffectonsplnal neuronsand without destructionofprimaryaffe rent
neuron term inals in the cord. Numerous studies have confirmed by
immunohistochemical or radioimmunoassay tec hniques, the SP depleting actions of
capsaicinin laboratory animals. In particular , a study by Furness and co-workers
(1982) found that capsaicin markedly depleted SP from nearly every vascular bed
of the guinea -pig. The exception to thiswas a group ofSP-conlaining fibres on
arter ies to the distal colon and rectum. The se investigators alsoconfirmed the
depletion of SPin the ureter , atrium andsupe rior mesenteric artery of capsaicin-
treatedanimals(Murphyt t aL, 1982). These resultsindicatethat the neurochemical
effects of cap saicin are specific for primal}'afferent neurons.
Since theoriginalresearchonthe denervatlon of SP-containingsensorynerves
with capsaicin, further studies using anatomical, histochemical and immunological
methods have revealed the presence of a variety of peptides in afferent neurons
(reviewedby Holzer. 1988). Functionalevidence indicatesa possible mediator or
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transmitter role for someof these substances. CORP isonesuch peptide which has
been shownto coexist withSP inprimaryafferent capsaicin-sensitivefibres (Lundberg
et al , 1985; Skofitscb arid Jacobowitz, 1985). Another peptide, VIP bas also been
loca lized in sensory afferent fibres but is not gen erally associated with SP. Usua lly
VIP is found inACh-containing nerve fibres with the exception of the cat, where
evidence has been found for its coexistencewith SP (Leah et al, 1985).
Most studies with capsaicin have been carried out on smallrodents such as
rats, mice and guinea pigs. At low doses, in the pglkg range, capsaicin causes a
powerful excitatory effect which is confined to small unmyelinated afferent nerv e
fibres or C-fibres (Kenins, 1982; Buck and Burks, 1986; Szolcsanyi, 1977). This
excitation is followed by a desensitization to capsaicin and blockade of impulse
conduction. Systemic administration of high doses, in the mg/kg range, has a
neurotoxiceffect on sensory neurons. The extent of this toxicity depends upon the
dosage, route ofadministration, species andage of the animals. The most extensive
and consistentlesions are produced by systemic treatment of newbornanimals. A
singledose of 50 mglkg results in permanent degeneration of 50%- 90% of all
unmyelinated afferent fibres in newborn rats with no significant change in the
myelinated afferents (Jancsoel at., 1977: Nagy et al., 1981, 1983). Specifically, in
guinea pigs capsaicin causes a marked depletion of SP and CORPfromcardiac SP·
and CGRP~contain ing neurons,while cardiacadrenergicand VIP-containingneurons
remain intact (Della el al., 1983; Lundberget aL, 1985; Pepkael al., 1981: Saito el
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or., 1986). At doses higher than 50 mglkg a reduction in the number of small
myelinated fibres is also seen (Nagy et at, 1983). Administration of SO mg/kg
capsaicin to adult rats results in less pronounced effects with no degeneration or
part ial degene ration of unmyelinated sensory afferents (Ja neso, 1981; Jancso et aL,
19B5). In the guineapig,which is moresensitiveto capsaicin than the rat, the same
dosecausesrapiddegeneration ofapparentlyunmyelinated fibres(Papkaet aL,1984).
It has been summarized that there are three major actions of capsa icin on
primary afferent neurons (Buck and Burks, 1983, 1986). The first effect is an
excitationwhichprobablyoccurs when capsaicin, a lipophilicmolecule, dissolves in
the plasmamembraneof the free ending of the nerve fibre. Capsaicin is presumed
to affect the fluidity and possibly the ion permeability of the plasma membrane.
Thesechanges resultin the flowofCal. and other ions acrossthe membraneaswell
as the releaseof sr. The secondeffect is a desensitization of the primarysensory
afferent neuronsto the peripheral stimuli. It is thought that capsaicin results in a
long lastingplasma membrane perturbationthat locksthe membrane ina depolarized
state. It is this inability for further depolarizationsto be initiated or propagated that
results in the sensorydeficitwhichhas been observed. Finally, capsaicin produces
a depletion of most of the SP contained in the primary afferent neurons. This is
caused inpart by thereleaseofsr thatoccursduringthe initial membraneexcitation.
However, the neuronis also unableto replenish its peripheral and central SP stores
becausecapsaicin hasa disruptiveeffecton the intracellular organelles includingthe
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microtubule system. Anyremaining vesicularSP may alsobe lostdue to capsaicin-
induceddisruption of the storage vesicles. II is not clear if capsaicin produces all
these effects by morethan one mechanismof action. It has been suggested from
structure-activity studiesthat the initial excitation and SP release in primaryafferents
are one actionand that the subsequent desensitization and sensorydeficits produced
by capsaicin aTCa separate action. There is as yet little data to support this idea.
Capsaicin waschosenas a tool in this study for depletion of the Sp·CGRP
afferent nerve fibre plexus in the mesente ric arte rial bed of the rat. It is a useful
agent because of itsspecificity of actionand long lasting effect when given in 3. 50
mglkg dose 10newborn rats at 2 daysold. However, although manystudies have
measured theeffectofcapsaicintreatment onnervefibres, verylittleis knownabout
itseffecton other tissuessuchas endothelium and vascularsmoothmuscle. Studies
on the acuteeffectsof capsaicinon blood vessels have indicatedthat it can have
two differenteffects. Capsaicin, whenadministered ill vitro, causesa vasodilation
which is independent of the presence of the endothelium but does not occur in
vessels from animals which have been treated with capsaicinin vivo to remove
sensory afferent innervation (Duckles, 1986; Donnerer and Lembeck, 1982,1983).
Thus,this vasodilatoryeffect is thought to be mediatedby an unknown transmitter
released fromsensoryafferentsby capsaicin. Insystemicallycapsaicin-treatedanimals
a contractile responseto capsaicin appliedill vitro is observed. This is thought to
be a direct excitatory action on vascular smooth muscle. The chronic effectsof
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capsaicin administra tion on vascular smooth muscleand endothelium arc unknown.
In addition, the effects of the vehicle treatm ent on vascular tissues have not been
described. The most common vehicleused for capsaicininjection.and alsoused in
this study, isa mixture of 10% ethanol and 10% Tween 80 in isotonic saline (Jancso
et at, 1977). However, in many studies the effects of capsaicin treatment arc
compared with a vehicle-treated control only. An untreated animal is rarely used
as a control for the vehicle treatme nt. Since the effects of this vehicle treatment
are unknown, it is suspect and must be considered to have pote ntial effects of its
own. Capsaicin was therefore used in this study, along with a vehicle and an
untreated control, 10 cause permanent degeneration of the primarysensoryafferent
nerve fibre plexus in the mesenteric arterial bed of the rat. As with many
pharmacologicalagents, the effectivenessof treatment is known to varywith the age
of the animal at treatment, the dose administered and the route of administration.
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MATERIALSAND METIlODS
In this study, dose response relationshipswere determined for substance P
and acetylcholine in the presenceof methoxamine in the isolatedperfusedmesenteric
arteri al bed of the ra t. These experiments were carried out on tissues from untreated
and vehicle-treated control animalsas well as groups of animals which had been
treated with 6-hydroxydopamine or capsaicin to provide a chemically denervated
model.
2.1. Tissue Preparation
The tissue chosen for this study was the McGregor preparation (McGregor,
1965) of the isolated perfused mesenteric arterial bed of the rat with some
modifications. Adult male Sprague-Dawley rats (12weeks,Charles River Canada
lnc.) were anaesthetized with sodium pentobarbital (Somnctcl, M.T.C.
Pharmaceuticals)35 mglkgintraperitoneal. A longitudinal midline incision was made
throughthe abdominal wall and the mesenteric bed wasspread onto a gauze square
dampened with buffer solution. The superior mesenteric artery was dissociated
from thesurroundingtissuesand ligated proximal to the abdominal aorta. A cannula
of PE·90 polyethylene tubing, (tntramedic,Becton Dickinson& Co.)whichhad been
heated with a flame and drawn out to a tapered end, was inserted distallyinto the
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superior mesenteric artery above the ligation and secured with 5-0 silk sutures
(Ethicon). At this point the superior mesenteric vein wascut just proximal 10the
porta l vein and the bed was flushed gently to prevent clotting.
Then the colicand ilea-colic branches of the superior mesenteric arterywere
quicklyligated (Figure 1).
SI
Figure 1. The mesenteric arterial bed of the rat.
Superior Mesenteric
Artery
Pancreato
Duodenal A.
'-----....>..-- ColicA.
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In addition, all primary jeju nal arte ries except the four most distal to the cannula
were tied off in groups and the mesenteric vein was tied off with the pancreato-
duodenal vessels. The tissue was removedfrom the animal by severing the vascular
pedicle.
Finally, the intestine was separated from the mesentery by cutting close to
the intestinal border, leaving only the cut ends of the tiny vessels on the intestinal
margin of the mesentery for the perfusate to flow from,
The tissue was suspended in a jacketed glass bath at 37' C and perfused at
a constant rate of 2 mUminute witha Krebs bicarbonate buffer (Hynes and Duckles,
1987).
The composition of the buffer solution wasas follows(millimolar): Na' , 147.6;
K', 6.4; Ca2' , 1.6; Mg2' , 1.2; cr- 130; HeO]-. 26; SO, 2. , 1.2; HlO,· ' 1.2; glucose,
11. Disodium ethylenediamine tetraacetate (EDTA) was not used. The buffer
was incubated at 37·C in a thermostated water bath and was aera ted with a gas
mixture of 95% 0 / 5% CO2, Pressure measurements were made using a Gould
Stat ham P23Dc pressure transducer and a Beckman Type R411 Dynograph recorder.
2.2. Apparatus
In these experiments perfusion pressure was measured from the isolated
mesenteric arterial bed. A schematic diagram (Figure 2) is presented to illustrate
the apparatus used.
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Figure2. A schematic diagram 10 illustrate the perfusion apparatus.
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Ir..-------- Cannula
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Stopcock---.....~J
Latex TUbing
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'1·.._------- To TIssue
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Duringthe dissection the tissuewasattachedto a 10mL syringe (Luer Lck,
BectonDickinson & Co.) with a 20 gauge1 inch needle (Precision Glide, Beeton
Dickinson & Co.)which had been filed down and inserted into the blunt end of the
polyethylenecannula. Thissyringewas filledwithwarmed oxygenatedbuffer 10 flush
the tissue during the dissection. When isolated from the animal. the tissue was
attached to the perfusion and detection apparatus by inserting the fitting of the
needle into a 2 em piece of latex tubing (4.8x 2.4 rom, Scimatco, Fisher Scientific)
which was connected to one port of a three way stopcock (Monoject) . The second
port of the stopcock was attached to a Gould Statham P23Dc pressure transducer
and a Beckman Type R411Dynograph recorderfor the measurement of perfusion
pressure. The third port of the stopcock was attached withsilicon rubber tubing
(2.9 mm 1.0., 4.9 rom 0.0., LKB) to an LKB2132microperpex peristaltic pump
whichsuppliedthe tissuewith bufferat a constantrate of 2 mUminute. Boththe
buffer and the jacketed tissue bath were kept at 37·C by a Haake immersion
circulator(model01, FisherScientific).
2.3. Drugsand Chemicals
The methoxamine usedin thisstudywasa giftfrom Burroughs Wellcome lnc.,
Kirkland, Quebec. Stocksolutionsof to-l M were made up in water,aliquotedand
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frozen until used for an experiment. Solutions were never refrozen for repeat ed
Acetylcholine chloridewasobtained fromSigma ChemicalCompany,S1.Louis,
Missouri. Stock solutions were made up in water, fresh for every experiment, and
were stored on ice duringthe experiments.
Substance P triacetate pentahydrate was purchased from Sigma Chemical
Company, 51. Louis, Missouri. Solutions of each concentration to be tested were
made up in distilled water, aliquoted and frozen immediately. Individual allqucts
were thawed just prior to injection. Substance P solutionswere never refrozen for
further use.
The collagenase used for removal of the endothelium was obta ined from
Gm CO laboratories, Burlington, Ontario. This prepar ation of clostradiop eptidase
A was a crude extract. Collagenase was used at a concentration of 0.2 mglmL,
weighed freshly and made up in regular buffer solutionfor each experiment.
SodiumnitroprussidewaspurchasedfromSigma ChemicalCompany,SI.Louis,
Missouri.Stocksolutionsof lO·zM were madeup inwaterfreshforeachexperiment.
The solutions were stored on ice and protected from Iighl during the experiment.
Angiotensin 11 was obtained from Sigma Chemical Company, St. Louis,
Missouri. A 1 mg quantity was dissolvedin 841 JlLof waterto achieve a 10'3 M
stock solution for each experiment.
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2.4. Animal Modeb
In thisstudy the action of twovasoactiveagents, acetylcholine and substance
P were studied in the isolated perfused mesenteric arterial bed of the rat. In order
to determine if the perivascular nerve fibres contribute to the development of the
abilityof theblood vessels to respond to these agents,experiments hadto be carried
out on tissues from animals wilh and without the normal nerve fibre plexus. In
total, five groups of animals were studied. The experimentalgroups consistedof
two modelsof chemically denervated adult maleSprague-Dawley rats. The control
groups were untreated adult male Sprague-Dawley rats, as well as two groups of
vehicle-treat ed animals 10 correspon d with the experimental models.
The first experimental group was a model of chemical sympathectomy.
Sprague-Dawley rats were treated from birth with 6-hydroxydopamine (6-0 HDA)
to prevent the development of the sympathetic nervous system. The 6-0HDA was
dissolved in a solution of phosphate buffered saline which had been boiled and
bubbledwith nitrogen gas to removedissolvedoxygen. Thissolution also contained
ascorbic acid (5 mg/mL) as an antioxidant and was adjusted to pH S with 1 M Hel
to further protect the 6-0 HDA. Rats were given a subcutaneous injection of 0.1
mL of this solution containing a dose of 60 mg/kgof 6-0 HDA. Injections were ad-
ministered on day 0, 1, 3, 5, 7, 9, 11 and weeklythereafter until the age of 12 weeks.
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The second experimental groupconsistedof maleSprague-Dawley rats which
had been treated with capsaicin from birth to destroy peptldcrgic peripheral
innervation containingthepeptides substance Pand CGRP. Capsaicinwas dissolved
in absolute ethanol (2 mL) and a mixture of Tween-80 (2 ml.) in 0.9% saline (16
ml.) wasadded. This solution needed warmingto dissolvethe capsaicin completely.
Rats were given a subcutaneous injection of 0.1 mL of this solution. Injections
were administered on day 2, 3, 4, IIand 25, followed by two further monthly interv als
until the rats were 12 weeks old. On day 2 the injections contained a dose of 25
m~g of capsaicin, with subsequent doses containing 50 mg/kg.
Control experiments were done on untreated and vehicle-treated rats. The
vehicleinjections consisted of the same solutions. volumesand intervals as described
for the experimental models,with the 6-hydroxydopamine or capsaicin omitted.
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2.5. Experiment Protocols
2.5.1. Methoxamine Concentration Response~iment
Methoxamineis an 01 adrencceptcr agonist which was utilizedas a pressor
agent throughout this study. In this experiment eight rats were used 10determine
the concentration response relationship for methoxamine (gift from Burroughs
Wellcorne Inc., Canada) in the mesentericbed.
Stocksolutionsof 1x 10'2M methoxaminewere made up in water, fresh for
each day. After dissection, each tissue was allowed 10 equilibrate for 60 minutes.
Then, methoxamine was added cumulatively to the perfusing buffer solution in a
concentrationrange from 1 x 10 '1 to 5 X lO '5 M. After the tissue had reached a
maximal plateau inpressure, ACh from a 10'2 M stocksolution in water, wasadded
to the perfusing solution to achieve a solution concentrationof 1 x 10'5 M. This
was done to determine the functional state of the endothelium in the preparation.
2.5.2 AcctylcholineExperiments
In thisstudyconcentration responserelationships weredeterminedfor ACh,
in the presence of tone inducedbymethoxamine, in the mesentericbed preparation
of five groups of rats.
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The experimental groupsconsisted of rats treated with6-0 HDA or capsaicin.
as previously described,to providemodels of chemically denervated animals. The
control groups were normal adult male Sp rague-Dawley rats, as well as vehicle-
treated animals to correspond with the two experimentalgroups.
In these experiments the mesenteric bed preparation was dissected and set
up as described previously. The tissue was allowed to equilibrate for 60 minutes
before it was challenged with 1 x 10.5 M methoxamine in the perfusing buffer for
a 5·7 minute exposure. Afler a further 30 minute equilibration period of perfusion
with regular burrer, the tissue was again exposed to methoxamine in the buffer at
a concentration of 1-3 x to-SM to induce a stable plateau of pressureof 75 to 120
mm Hgabove the basal pressure. Then. cumulative additions of ACh were made
to the buffer in the range from 1 x 10" to I X to·! M stepwise. Only one dose
response experiment wascompleted for each tissue.
The dose-dependent reductionsof pressure to acetylcholine were calculated
as percent reductions of methoxamine indr- . d pressure.
2.5.3. Substance P Expe:rimeots
A series ofexperiments were carried out to investigate the actionof substance
P in the isolated perfused mesenteric arterial bed of the rat. Dose response
relationships were studied for substance P in the presence of methoxamine in six
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groups of Sprague-Dawleyrats. As for the acetylcholine study, fats were treated
with6-0HDAor capsaicinfrombirth10 provide twomodelsofchemicaldenervaticn.
Control groups consiste d of normal adult rats as well as the two corresponding
vehicle-treated groups. In addition, substance P was studied in the presence of
methoxaminein preparationswhichhadbee ndenudedofendothelium. Subsequently,
experiments were done to further investigatethe mechanism of actionof substance
P in this preparation. These studies involved the administration of substance P
before methoxamine exposure,as wellas substance P in the presence ofAngiotensin
II Of elevated potassium concentrationin tile buffer.
It was determined in preliminary experiments that SP is susceptible to
hydrolysis ina heatedbuffersolutionsuchas thatused toadminister the methoxamine
and ACh. This wasnot found to occurwithACh or methoxamine: over the time
course of the experiments. It also required a substantial amount of the synthetic
peptideto addit to thepe rfusingbuffer solution,whichcouldbeextremelyexpensive.
However, when injections ofa 10 JlLdose of stock solutions rangingfrom to'l to
lO'5Mwere givenat the injection port (figure2, page 54) pressor responses were
obtained. An injection artifact was ruled out by injecting 10~L of the solvent
(HP) andobserving no responsein the tissue. Hjghervo lumes(2: 100~L) were found
to givea transient artifact pressure response. ThereforeSP wasadministered asan
injected bolus dose in contrast to the cumulative concentrations of ACh in the
perfusing buffer.
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(a) Substance P in the Presence of Methoxamine
In thisgroup of experiments the mesenteric bed was dissected and sci up as
previously described. After an equilibration period of 60 minutes the tissue was
challenged with 1 x 10,5 M methoxamine in the perfusing buffer for a yeriod of
5-7 minutes. The tissue was then perfused with regular buffer and allowed to
equilibrate for a further 30 minutes. At this time the tissue was again exposed to
1 x to-S M methoxamine in the b uffer. As soon 85 the stabl e plateau of pressure
was reached, a control injection of 10J,LL of water was delivered with a Hamilton
syringe through the latex tubing which attached the tissue to the recording and
perfusion apparatus. Then, at five minute intervals, two further injections of 10 j,LL
of SPdissolved in water were made at the same site of injection. Finally, after the
second response to SP was obtained,a 10 J1L injection of 10'2 MACh was made
to indicate the functional state of the endothelium.
Concentrations of SP from lO-12M to 10-2 M were tested and a range from
10-5 to 10-2 Mwas chosen for measurement of the dose response relationship. Doses
of SP were calculated based on the 10 ~!.. volumeof injection of the to·s to lO-2
M solutions. Finally, to avoid desensitization,only twodoses of SP were givento
each tissue. The dose response data was expressed as both the actual change in
perfusion pressure and as the percentage increase in the methoxamine induced
pressure measured just prior 10 the injection of SP.
62
(b) Substance P in Endothelium-Denuded Preparations
To determine if the endoth elial cells lining the blood vessels of the mesenteric
bed were necessary (or Ihe action of substance P in this tissue, it was of interest to
study tissueswhich had been denuded of endothelium, Removal of the endothelium
was attempted by: flushing the tissue rapidlywith buffer solution duringdissection,
allowingair to perfuse through the tissue for 5 minutes, and by a combination of
a treat ment with collagenase in the buffer and an air emb olism. Electron microscopic
examinationof preparations trea ted by these methods indicated incomplete removal
of the endothelium for the first two methods. The combined treatment with
collagenaseand air resulted in a tissuewhichwas free of endothelial cells.
Six normal adu lt male rats were used for these experime nts, Th e mesenter ic
bed wasdissected and set up as previously described After equilibrationwithnormal
buffer for 60 minutes. the tissue was challenged with. I x lO's M methoxamine in
th.ebuffer and wastested for functioning endotheliumwith 10's M ACh in the buffer.
After a washout period of 5 minutes the tissue was exposed to collagenase 0.2
mg/mL in the perfusing buffer for 60 minutes. Following this treatment, an air
bubble wasallowed to perfuse through the tissue. The preparation was allowedto
equilibrate with regular buffer for 15 minutes and was then exposed to 1 x 10-5 M
methoxamine in the buffer. When a stable plateau of pressure had been reached,
two 10~L injections of SP from 10-6 to 10'2 Mwere given, followed by 10'S M ACh
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in the perfusing buffer. In addition a 10 $.lL injectionof lO-2 MACh wasgiven to
test for relaxations. Finallysodiumnitroprusside wasgiven, 10. 5 Min the perfusing
buffer, as well as a 10,tlLinjection of lO-l M to ensure that the preparation could
relax to a direct stimulus.
The responses toSP det ermined inthe preparationswhich hadbeen denuded
of endotheliumwere expressed as the control data for SP had been.
(c) Substance P Before Methoxamine
To further investigate the mechanism of action of subs tance P, experiments
wer e done in which SP was administered before the tissue had bee n exposed to
methoxamine. These experiments involved the use of sixnormal adult male rats.
Tissues were dissect ed and set up as previously described. Mlcr an
equilibration period of 60minutes, a control injection of 10~L ofwate r was given.
This was followed, after five minutes, byan injection of 10ilL of 10-2 M SP. After
an additional five minutes, the tissue was exposed to 1 :: 10'5 M methoxaminein
the buffer. When a stable pla teauof pressure was reached, the tissue wasgiven two
10 ilL injections of tO,l MACh.
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(d) Substa nce P in the Presence of Angiote nsin II
Tofurther study the mechanism of action of substanceP in this tissue, it was
necessary 10determine theresponseto SPin the presenceofa p ressor agentwhich
activa tes a different re ceptor system. For this purpose, Angiotensin II was used.
The experiment wascarriedou t using sixnormal adult malerats.
Thetissue was againdissected and set up as previously de scribed. After 60
minutes of eq uilibration the tiss ue was exposed to 111 lO,s M Angiotensin II in the
perfusing buffe r. A co ntrol inject ion o f 10 ~L of wat er was given 10 the tissue,
followed by an injection of 10 ""L oC10 '2 M SP. Finally, a 10 ~L injection of 10-2
MACh was givento checkthe integrity of the endothelium.
The responses of the tissue 10 this dose of SP we re expressed as absolute
change s in perfusion pressure.
(e) Substance P in the Presence of Depolarizing Buffer
The response of the bed to substance P in the presence of a depolarizing
buffer wasstudied in this serieso f experiments. Th edirect substituti on of potassium
chloride forsodiumchloride in th e perfus ingbuffe r gave a solution which would elicit
a pressor responseby acting directly on the smoo th muscle cellme mbrane to cause
a depolarization. Six normal ad ull male ratswe re used for this study.
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The mesenteric bed was diss ected a nd prepared as previously described. After
a period of60 minutes of equilibration with regularbuffer, thebuffer was changed
to a similar solution with an incr eased potassiu m concen tration of 40 roM and a
decre ased sodiu m concentration of 86.8 roM. This buffe r solution wasalso wanned
to31- C and oxygenated. After a stable pressor response was att ained, the tissue
was given a control injectionof 10 jJLo f water whichwa s followed, at five minute
intervals, bya 10 pL injection o f lO"z M SPand 10 ilL injection of 10-2 M ACh.
The responses to SPwere measured and expressed interms ofactual change
in perfusionpre ssure.
25.4. Immunohis tochemical and Electron Microscopic Study
In addition \0 recording responses o f the M cGregor prepa ration to
pharma cological agents, this study examined the tissue pr eparation at both the light
andele ctron micr oscopic level to verify the presenc e or absente of the perivascular
nerve fibres and the endot helium .
Tissues were fixed after th e experiments with Zambeni's fixative (Za mboni
and De Martino, 1967). The me senteric bed pre parations were flu shed gentlywith
fixative from a syringe and then immersed in the solution for 1 hour. Tissues were
then sto red in ph osphate buffere d saline (PBS) a nd the a rterial bed was dissected
oet of the surro unding f~ ~ and conne ctive tissue with the aid of a d issecting
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microscope. Tbe arte rial bed, which now included the superior mesenteric artery
and four primary jejunal vessels withth eir subsequent br anches, wassubdivided (or
immunohistochemical processing or p rocessing for electron microscopy.
(a) Immunohistochemistry
Tissues were sta ined using immunohistochemical techniques 10visualize lhe
perivascular nerv e fibre plexus at the adventitia l-medial border of the bl ood vessel
wall. Sections of the mesenteric bed which contained a segment of superior
mesentericarte rywith at least o nc attached primaryjejunal artery with its branches
intact were processed whole us ing a three step peroxidase anti-perox idase (PAP)
proced ure. Vesselswere washed ina solut ion containing phospha te buffere d saline
(PBS). 1%Triton X·too, and1% nannal goalserum for one hour before incubation
in primary antiserum. Thissolu tionwas usedas an antibody diluent as well as (or
rinses. The primaryantisera used were anti-substanceP (1:2000; Immunonuclear )
or anti-tyrosine hydroxylase (1:10,1:00; Eugene Tec h). The tissues were incubated
in the primary antisera for 36 hours at 6· C. After thre e IS-minute washes, the
vessels were incubated in a linking antibody,goat anti-rabbit (1:50 Sternberger) (or
2 hours and, following a further three washes, the tissues were incubated in rabbit
PAPcomplex ( 1:300; Sternberger) for 2 hours. Then, after the final three washes,
the tissues were reacted with a solution containing diaminabenzidine (50 mg) in
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distilled water (SOmL) with 0.2 M phosphate buffer (SOmL) and 30~ hydrogen
pe roxide (33 ilL). After the reaction was co mpleted (1-2 min utes) the tissues were
dehydrated with75% ethanol, absoluteethanol,and xytene for ISminutesea ch and
mounted on slides as whole mounts withE ukittmounting medium.
The presence of a nerve plexus,specificto the primaryantibodyused, was
determined by light microscopy.
Controls for the immunohistochemical stainingmethod were carried Qui as
desc ribed above with one of the steps altere d or omitted. The procedure was carried
out with primary antiserawhichhad been preadsorbedwith antigen, with pr imary
antisera omitted. or with the PM linkingantibodyomitted10 ensure th atthe re action
product was due 10 specifIC labelling.
(b) Electron Microscopy
Tissues selected for electron microscopywere placed in individual labelled
vials and kept on a rotating stirrer to ensure complete mixing th roughout the
processing. Theywere immersed in sodium cacodylate buffer (0.1M) for 30minutes,
and then posttlxed with osmiumtetroxide(1% incacodylate buffer) for 1hour. After
en blocstaining with uranyl acetate (saturated in 50% ethanol) for 30 minutes, the
tissues were put througlt a dehydra tion sequence, beginning with 70% and 9S%
ethanol for 30 minutes each. Then, the tissues were further dehydrated with 3
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changes of ab solute e thanol and cleared with two cha ngesof absolute acetone for
10 m inutes each. Th e tissues were infiltra ted in a 50:50 mixture of resin and
acet one overnight at 6'C. The resin was mad e up using 16g of Epan 8121 8 g of
DDSA (Dodecenyl Su ccinic Anh ydride), 8gof MNA{MetbylNadicAnhydride) and
0.4 g ofDMP 30 (2,4.6-tri{dim e thylami nometh y l) phenol). In the morning the tis sues
were immersed infresh resin for 4hours on th e rotating stirrer andpo lymerise d in
Epa n resin in nat embedding molds overnight al 60·C. Prior toemb edding and
polyrnerisation, the superior mesenteric bed a nd itsbran chingjejunal arteries were
sepa ra ted an d labelled.
Sectio ns 1~m thick we re cut and stain e d with toluidine blue. Thin sect ions
were stained withlead citrate and exami nedin a Philips EM300 electron microsco pe.
The presence of intact endothelium a nd perivascular nerve fibr es was determined
from examina tion of the thin sections. With the exceptionof the inte ntionally air
embo lized tissues, dat a was not used for tissues which werefoun d to have damaged
or removed e ndotheliallinings .
25.5. Statistics
Statistical analysisof th e data was comp leted usingthe SPSS·X package on
the VAX/VMS computer at Comp uting Services, Memorial Uni versity of
Newfoundland. A oneway analysisof variance (ANO VA) was carried out on the
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data fromeachanimalgroup to determine if a dose response relationship exists for
the acetylcholine or substance P experiments. The Scheffe test for significance was
used in these procedures(P<O.OS was considered significant).
From themeansand standard errors of the means, calculatedby the ANOVA
procedure, dose-responsecurveswere constructed for eachgroupusingtheSigmaplot
package on aTatung TCS-7000personalcomputer. The E<;,ovalueswere obtained
by graphicallycalculatingthe concentration of agonist producing50%of itsmaximum
response using the method of Fleming el aL (1972). To test for differences in the
dose -response relat ionships for an agonist with the chemical denervation animal
treatments, a twoway ANOVA procedure was used. Differences indicated by the
ANO VA were considered to be significant for P<O.OS.
In experiments where an ANOVA was not used, the means and standard
erro rs of the means were calculated using a Hewlett Packard Hp·I IC calculator.
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RESULTS
3.1. Immunohistochenililtry Results
Upon examination by lightmicroscopy, the mesenteric arterialbed preparations
of the untreated animalgroups were foundto exlubita nervefibre plexuswhichwas
disposed in two planes. Bundles of large diameter fibresappearedto run along the
cuteradventitia,whileat the adventitial-medial border a plexus offiner beaded fibres
occurred. This layering of the perivascular nerve fibre plexus has been previously
described (SCOltet at, 1987). Although the for m and extent of the fibre plexuswas
different for SPand TH, both appeared to exist in two planes withthe outer fibres
appearing smooth and the deep plexusdisplayingvaricosities.
The tissues from the capsaicin-treate d group did not display SP
immunoreactivity at either layer in the mesenteric arterial bed. However, the
preparations stained for TH revealed nervefibres at both layers in allvessels of the
bed. The density of these fibreswas not measured.
Tissues {rom6-0HDA·treated rats stained positively for the SP·containing
nervefibres at both levels. However, tissuesstained for 11-1 did not have the fine
deep fibre plexusobservedin the controlsbut somelarge fibres werestill present
in the outer adventitia.
11
3.2 Metho:wnine Conccotralion Response F..lperiment
Methoxamine wasshownto exhibita gradedconcentration responserelationship
in the isolated perfused mesenteric bed (Figure 3) . In the ACh experiments a
concentrati on of 1-3xlO·5 M methoxamine was used to achievea stable plat eau of
pressure fromwhich therelaxationsto ACh could be measured. Inthe concentration
response curve to methoxamine this conce ntration range can be see n to give a
submaxima l 10 maximal pressor effect in this preparation.
3.21. Meth oxamine Response in Capsaicin-treated Rats
It wasfound in this study that the response of themesenteric arterial bed 10
methoxam ine was increased in tissues from capsa icin rats (Figure 4). At a
concentrationof 1x 10-5M methoxamine in the perfusingbufferthe pressorresponse
wassignificantlyhigher in tissues fromcapsaicin-trea ted rats. A change in reactivity
of the prep arations from capsaicin vehicle-treated rats to methoxamine was not
observed.
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Figure 3. Concentrationresponse curvefor methoxamineinthe isolated perfused
mesentericbc:d of untreated rats. Standarderrorsare indicated(n- S).
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Figure 4. Th e responseof the mesentericarterial bed 10methoxamine in tissues
from ca psaicin-treated rats. Standard errors are indicated (0==10).
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3.2.2 Methoxamine Response in &aHDA-treated Rats
A decreased reactivity of the mesenteric arterial bed to methoxamine was
not iced in preparations from 6-0HDA·treated rats in this study (Figure 5). The
pressor responseto 3 x 10-5 M methoxamine in the perfusing buffer was significantly
lower in tissues from 6-0 HDA·treated rats than those from untreated or vehicle-
treat ed groups.
3.3. Acetylcholine Experiments
Acetylcholine caused a concentration dependent reduction inthe methoxamine
induced pressure in the mesenteric bed preparation. Figure 6 shows the graded
concentration response relationship for ACh in the untreated animal group.
3.3.1. Capsaicin-treated Animals
A significant decrease in the sensitivityof tissues to ACh was detected by the
two way ANOYAfor the capsaicin-treated group of animals. The concentration
response curve (Figure 7) is shifted f'j the right 1.2 log units. The corresponding
ECso values are shown in Table 1.
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Figure S. The response of the mesenteric arterial bed to methoxamine in tissue
from 6-0HD A.treated rats. Standard errors are indicated (n= 6).
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Figure 6. Concentration response curve foracetylcholine in tissues from untreated
rats. Standard errorsare indicated (0""10).
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Figure 7. Concentration response curves for acetylcholine in tissues from
untreated and capsaicin-treated rats. Standard errors are indicated
(n=9).
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Tab le 1. ECso Values (or AcetykboUne
Treatment E<;o [M]
untreated 1.45 x 10"
capsaicin 2.34 x 10-1 •
6-0HDA 1.29 x 10"
capsaicin vehicle 3.89 x 10-'
6-OHDA vehicle 7.24 x 10.9
This value was found to be significantly different at P<O.05.
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The E<;o for ACh in the caps...o::in vehicle-treated animal group is not
significantlydifferent from the untreated group. Figure g shows the concentration
responserelationshipfor AChin the untreated,capsaicin-treated andcapsaicinvehicle-
treated animal groups.
3.3.2. 6-Hydroxydopamine Treated Animals
No significant change in the sensitivity of tissue s to ACh was de tected by the
two-way ANO VA for the 6-0HDA·treated group of animals. In addition, no
difference could be shown between the responses in the 6-0HDA vehicle-treated
group and the untreated animals. The concentration response curves for the three
groups are shown in Figure 9.
3.4. SubstanceP Experiments
Substance P was shown to cause a dose dependent augmentation of the
methoxamine induced pressure in the isolated perfused mesenteric bed of the rat
(Figures 10, 11). In preliminary experiments on untreated rats, SP concentrations
as lowas IpM did not result in relaxations in the tissues. In these experiments the
tissues did exhibit reductions of methoxamine induced pressure in response to ACh
(lO' ~ M). This response was not changedupon removal ofthe endothelium (Figures
10, 11).
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Figure 8. Concentration response curvesfor acetylcholinein the mesentericbed
of untreated, capsaicin-treated and capsaicin vehicle-treated rats.
Standard errors are indicated (0=9).
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Figure 9. Concentrationresponse curves (oracetylcholine intissua fromuntreated,
&-OHDA-lrealed. and 6-OHDA vehicle rats. Standard errors are
indicated (n=8).
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Figure 10. The dose response relationship {or substance P in untreated and air
cmbolized tissues. Data is expressed as absolute change in perfusion
pressure(mmHg). Standard errors are indicated (n=6).
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Figure 11. The dose response relationship for substance P in untreated andair
embolized tissues. Data is expressed as the percentage increase in
methoxamine-induced pressure (mmHg).Standarderrorsarc indicated
(n-6).
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Since Ihis appeared to be a potentiation of the adrenergic vasoconstriction
the pressor response to SP was calculated as a percentage increase in the
methoxamine bduccd pressure measured just prior to the injection of SP. When
expressed as an absolute change in perfusion pressure the SP dose response
relationship is not altered in the treated animal groups (Figures12, 13). However.
when the dose response data is expressed as a percentage potentiation of the
methoxamine induced pressure 6-0H DA treatmen t resutts in an increase in the
pressor response at the 10" mole dose (Figure 14). No significant change is seen
withcapsaicintreatment althoughthe response at the 10-7 moledoseappears to be
depressed (Figure IS).
3.4.1. Substance P Before Methoxamine
When a 10-' mole dose of SP wasgiven to tissues before methoxamine buffer
no measurab le response was seen. These tissues did respond normally 10
methoxamine and ACh alter the SP injection.
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Figure 12. Dose response relationships for substance P intissues fromuntreated,
capsaicin-treated and capsaicinvehicle-treatedrats. Datais expressed
as absolutechange in perfusion pressure (mmHg). Standard errors
are indicated (0=6).
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Figure 13. Doseresponse relationships forsubstance P intissuesfrom untreated,
tH)HOA-treated and6-OHDAvehicle-treated rats. Data isexpressed
as absolute change in perfusion pressure (mmHg). Standard errors
are indicated (n::12).
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Figure ]4. Dose response relationships forsubstance P intissues from untreated,
6-0 HDA-treatedand6-0 HDAvehicle-treatedrats. Data isexpressed
~'1 the percentage increase ofmethoxamine-inducedpressure(mmHg).
Standard errors are indicated (0=12).
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Figure 15. Dose responserelationships forsubstanceP intissues from untreated,
capsaicin-treated andcapsaicinvehicle-treatedrats. Data is expressed
asthepercentage increaseofmethoxamine-inducedpressure (mmHg).
Standard errors are indicated (0=6).
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3.4.2 SubstanceP in the Presenceof Angiotensin n
When a 10'7 mole dose of SP was injectedinto tissues perfusedwith buffer
containing 10'5MAngiotensin II asa pressor agent,a smallbut measurable pressor
response WdS obtained (Figure 16). This response was highly variable.
3.4.3. Substance P in the Presenceof Depolarizing Buffer
When a 10-1 mole dose of SP was injected into tissues perfused with 40 ITlM
potassiumdepolarizingbuffer, a smallbut measurable pressor responsewas achieved
above that caused bythe buffer(Figure 16). This responsewasalsohighly variable.
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Figure 16. The response to substance P in the presence of Angiotensin II and
depolarizing (K·) bufferin the isolated perfused mesenteric arterial
bed of the rat. Standarderrors are indicated (n=6).
'"J:
E
5
70
60
50
40
30
20
10
o.1----'_-'--'
D Angiotens in II D 40 mMK+ Buffer
m SP in the Prese nce of Ang II fR'.l SP in the Presenc e of K+
91
DISCUSSION
This study has found that chronic capsaicin treatment causes a decreased
sensitivity to AChin the mesenteric arterial bed of the rat which is indicated bya
shiftintheconcentrationresponse CUNC forthisendothelium-dependent vasodilatory
response (Figure7, page77). Nosignificant change in sensitivity of the preparation
to ACh was noticed with capsaicin vehicle, 6-0HDA, or 6-0 HDA vehicle-treated
groups (Table I, page 78). In this same tissue preparation SP caused a pressor
response which was independentof the presence of endothelial cells (Figures 10,
II, pages 82, 83). Whenexpressed asa percentagepotentiationof the methoxamine
response, 6-0HDA treatment resultedinan increased SPresponse (Figure14,page
87).
4.1. Consideration of Dener:vation Treatments
To compare the responses to AChand SPof the mesenteric bed preparations
between tissues from untreated, capsaicin and ~OHDA·treated animals a
consideration of the success of these treatments must be undertaken.
Capsaicin treatment was foundto remove the SP-immunoreactive nervefibre
plexus completely in the mesenteric arterialbed in this study. Thisis not surprising
sincethe treatmentwasinitiatedat 2daysafter birth andwasquite rigorous. Studies
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have shown that it is possible to completely remove SP innervation from the
mesenteric arterial bed of the rat withthis son of capsaicin treatment (Murphytt
aL, 1982). Because the density of innervation was not measured, it is not known
for sure if an increase in TH-containing adrenergic fibres occurred with capsaicin
treatment. However, it has been reportedthat this can occur (WooigarandScott,
1989).
The 6-0HDA treatmentwas shownto removethe fine beaded TH-containing
fibre plexusat the adventitial-medial border. Since this is thought to be the terminal
plexusof the sympatheticnervesin the bloodvesselwall, a functional sympathectomy
wasachieved. However, large Tl'l-ecntaining fibres remainedin theouter adventitia
of many6-0HDA-treatedpreparations.Althoughthesefibres do notappear tohave
varicosities fromwhichtransmitterwouldbe released, their presencemeans that NA
is present in the blood vessel wallduringdevelopment. The complete removalor
sympatheticinnervationwith 6-OHOAisdifficult 10achieve inthe mesentericarterial
bed but studieshave shownthai it ispossible with neonatal treatment(Angeletti and
Levi-Montalcini, 1970). Treatment with 6-0HDA did not appear to inhibit the
development or the SP nervefibre plexus. Whether SP perivascular innervation was
increased in these tissues was not measured.
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4.2 Factors Contributingto the Alteration of the ACh Response
Thedecreasedsensitivityto AChin this tissue withchronic capsaicin treatment
has not been previouslydescribed. Although a high variabilityin measurements in
this preparation has been encountered, it is unlikely that the observed shift in the
ACh concentration response curve isan artifact. A substantial number of animals
were usedso that reliable means for the responses were obtained. Statisticalanalysis
of data using an ANOYA indicated that a significant difference (P<O.OS) existsfor
the capsaicin-treated group but not for the 6-0HDA or vehicle-treated groups.
Therefore a change in one or more elements of the blood vessel wall must be
assumedto have caused the observed shift of the ACh response. What components
of the mesenteric arteries might be involved in such a functional change? The
decreasedsensitivity to intraJumenally administered ACh could have resulted from:
(I ) a change in the muscarinic receptor density
(2) a change in intracellular events in the endothelial cells
(3) a change in the abilityof EDRF to diffuse to iu site of action
(4) changes in the smooth muscle relaxing ability
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4.2.1. Changesin Muscarinic ReceptorDensity
A decreased EDRF response of the preparation to AChwould occur if the
muscarinic receptor population of the endothelium was decreased. The muscarinic
receptor densitywasnot directlymeasured in this study. However, theuse ofagonlsts
which activate other receptor systemson the endothelium to produce EDRF would
provide data for a comparison of receptor effects. The original use of SP in this
projectwasas an agonistwhich causesendothelium-dependent relaxationsbyactivating
a different endothelial receptor population (Zawadzki et aL, 1981). Other agonists
which might be useful for further study into this question of muscarinic receptor
population change are bradykinin and A23187. Bradykinin is another potent
endothelium-dependent vasodilator which is thought to act viaa receptive substance
on the endothelium (Altura and Chand, 1981). The use of the lonophore, A23187,
to produceendothellurn-dependent relaxations in the treated and control groups of
this studywould provide data for comparison (Zawadzkit t aL, 1980). If responses
to A23187 were not altered with capsaicin treatment, then the shift in the ACh
responses would most likely be due to a change in the density of muscarinic
receptors.
A changein the muscarinicreceptor population of vascular endotheliumwith
removal of the SP· and CGRP-containing innervation is quitepossible. It has been
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reportedthat both SP and CGRPcanhave an influence on the development ofACh
receptors (Boyd and Leeman. 1981; Newand Mudge, 1986).
4,2.2 Changes in Intracen~ Eventsof the Endothelium
A decrease in the abilityof endothelial cells to generate and release EDRF
wouldalsoresult in a changein sensitivity of the mesentericbed to ACh. Several
observations stronglysuggest the existence of more thanone EDRFandas suchmore
than one synthetic pathway is likely to be involved (Vanhoulle, 198730). While
productsof arachidonicacid via the cytochromeP450 pathway, or even ammonia,
have beensuggested as possible mediatorsof endothelium-dependentrelaxation, NO
isthe onlycompoundwhichhasbeenpositivelyidentifiedas an EDRFso Car (Palmer
fLai,1987) . Palmer andcolleagues havesincereportedevidence for the involvement
of Le rginine as the endogenous substrate fromwhich NO is generated in vascular
endothelial cells(Palmeret aJ., 1988). This pathwayappears10 involve twlldistinct
steps, the initial mobilization of the substrate (Lerginine) and then its conversion
to NO. These steps are both activated uponendothelialstimulationby bradykinin
and A23181. If availabilityof endogenous substrate is altered, the NO·generating
enzyme iscapableofutilizingexogenoussubstrateeffectively. The actual mechanisms
bywhichrelease of Larginlne and activation of this NO·generating t occur
has not yet been reported.
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It is not knownwhether changesoccurredin any of these EDRF generating
pathways in this study. However, to fully investigate Ihis possibility the use of a
cascadesystemof arteries is required. Many studies of the mechanism of EDRF
production and release have utilized a donor tissue with intact endot helium and a
bioassay strip of artery from which the endothelium has been removed(Ruban'; el
aL, 1985). The usc of such a preparat ion would allow a separation of the effects
oi changes in several different components of the blood vessel prepar ation. If the
bioassaystrip relaxed to the sameextent withequalconcentrationsof AChin perfused
mesentericbed preparations fromuntreatedand capsaicin-treated rats, then it might
be assumed that the previouslyobserved shift for ACh was due to changes in the
abilityof the smooth muscle 10 relax,rather than a loss of EORF producing ability.
However, ifthe same decreasedsensitivity 10 AChwasobserved,furtherexperiments
with an inhibitor such as indomethacin would be required 10 block the synthesis of
prostaglandins and some of the effects of EDCF. This might determine if the
vasodilator abilityof the endothelium had been altered due 10 an increased basal
release of contracting factors. Finally, although the enzymesystem involved in the
productionof NO has not been fullycharacterized, the addition of Lerglnlne to the
ACh solution mighl improve the ACh response if the mechanism by which the
substrate for NO production is mobilized were altered by capsaicin treatment.
It is not knownwhat effect long-term capsaicin treatment mighthave on the
biochemical pathways involved in the production of EDRF.
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4.2.3. Cilanges in the Diffusionof EDRF
It is possible that the diffusion of EDRF after its release from the endothelium
might be limited by morphological changes in the intimal medial region of the blood
vessel wall. This would also result in an altered response to ACh in the mesenteric
arterial bed.
In this project, the endothelium was visualized with transmission electron
microscopy. Electronmicroscopicexamination of arteries from the mesenteric bed
of the capsaicin-treated rats did not reveal any intimal thickeningor ultrastructural
damage. Thus, the decreased sensitivityof the preparation to ACh in the capsaicin-
treated group is not likelyto be due to a change in the ability for EDRF to diffuse
to its site of action on the medial smooth muscle.
4.2.4. Changes in Smooth Muscle Cells
A major factor which may contribute to the decrease in vasorelexation is a
change in the ability of the smooth musclecells 10relax. The relaxationof vascular
smooth muscle in response to EDRF is mediated by guanylate cyclase via the
production ofcyclic GMP and the activation of cyclic GMP-dependent proteinkinase
(Vanhoutte etaI., 1986; Rapoport and Murad, 1983a). This results in altered protein
phosphorylation anr; in dephosphorylation of the myosin lightchain which is though
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to lead to relaxation. This actionof EDRF onvascular smooth muscle is dependent
on Caz+ and is thought II}be the mechanismbywhichNO and the nitrovasodilators
act (Vanhoutte, 1987a) Another EDRF is thought to act via activation of the Na' ;
K+·ATPase and is thus K+ dependent (Rubanyi and Vanhoutte, 1988). Thus, an
alteration in these intracellular pathways would affect the ACh response.
In this study, ACh was the only vasodilator agent whose responses were
compared in tissues from untreated and denervated animals. SNP was wed as an
endothelium independentvasodilatoragent in some preliminary experiments in the
ACh studyand also in part of the SP study. Therefore, it is not knownif capsaicin
treatment affected the relaxing abilityof the smooth musclecellsof the preparations.
However, if SNP had been used at the end of the ACh concentration response
experiment, it would be possible to detennine if the tissue had relaxed fully. A
comparison of theSNPinduced maximal levelof relaxation inuntreatedandcapsaicin-
treated animals woulddeterminewhetherornotthe relaxingabilityofvascular smooth
muscle had been altered.
It was alsofound in thisstudythat theresponse to methoxaminein capsaicin-
treated rats was increased. The perfusion pressure increase to methoxamine was
significantly higher in tissues from capsaicin-treated rats than that for an equal
concentration inuntreated orvehicle-treatedcontrols(Figure4,page 73). Whateffect
of capsaicin treatment could have causethis? It has been reported that peptidergic
denervation withcapsaicin may result in an increased densityof catecholaminergic
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innervation in the rat mesent eric vascular bed (Woolgar and Scott, 1989). It is likely
that an increase in calecholaminergic nerve fibres during development will result
in an increased reactivityto adrenoceptor agcnists such as methoxamine. Whether
this change in sympathetic innervation will contribute to changes in the EDRF
response is unknown.
From these experiments it has been determined that long term capsaicin
treatment results in a change in the endotheliumdependent relaxations to ACh in
the mesenteric arterial bed of the rat. From the present study it can be concluded
that this decreased sensitivity wasnot due to the inability for EDRF to diffuse from
the endothelium to the smooth muscle. However, it cannot be determined if the
effect is a result of changes in muscarinic receptor density, alteration of endothelial
cell biosynthetic pathways, or changes in the abilityof vascular smooth muscle to
relax.
The decreased EDRF response to ACh in the mesenteric arterial bed of the
rat withlong-term capsaicin treatment has not been previously reported. However,
a depression of the EDRF system has been describedin other situations, some of
which are also associated with changes in perivascular innervation.
Hypertension is a disease withwhich many changes in vascular structure and
function have been associated. In various models of hypertension, certain blood
vessels showa depression of endothelium-dependent relaxations. Decreased EDRF
responses have been reportedin bothaortaand smallvesselsand genetichypertensive
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rats (Konishi and Su, 1983; Winquist et ai., 1984; DeMey and Gray, 1985), aortic
coarcted rats (Lockeue et aL, 1986), mineralocorticoid hypertensive rats (Mayhan
et at; 1987), Dahl hypertensive rats (Luscher et at , 1987), and in aortic coarctation
hypertensive rabbits (Miller et at. 1981). Although the finl\l measured result was
a depression of relaxation in these experiments,several different mechanisms may
be involved. In some cases an endothelium-derived contractile factor appeared 10
cause the depression, while in another experimentcomparisonwitha SNP response
suggested a lowered production of EORF. It has been found that, although EDRF
responses may bedepressed in onevessel.an increased relaxation may occur in other
vessels from the same animal (Konishi and Su, 1983). In estrogen treated rats, an
increase in relaxation to ACh but not the ATP has been reported (Williams et 01.
1988). Hypenension appears to have a selective effecl on the action of some
endothelium-dependent vasodilators but not others (Lamping and Dole, 1987).
In hypertension changes occur in the type and pattern of perivascular
Irmerveticn. It has been reported that there is an increase in the density of
catecholaminergicfibres in certainvascular beds during development of hypertension
in the spontaneously hypertensive rat (Scott and Pang, 1983; Dhital et 01., 1988;
Donohue el aL, 1986). Some changes have also been reported in peplidergic
innervation of blood vessels in hypertension but these are not universal (Scott et 01.,
1986; Lee et al , 1988).
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Diabetes is a disease which involves alterations in vascular structure and
function. In diabetic rats, endot helium-dependent relaxation has been shown to be
impaired(Durante et al., 1988). although conflictingreportsdo exist (Oyamaet al.,
1986; White and Carrier, 1986; Wakabayashi el aL, 1987). The variation in
observations may be related to the experimental models of diabetes used (genetic,
streptozotocln, alloxan) or they may simply reflect differences due to variation
betweendifferentvessels. Duranteand co-workers(1988)haveconcluded fromtheir
experimentswith aorta of geneticallydiabetic rats that a changein the synthesis of
EDRF hasoccurred, since the decreased vasodilation was the same for both ACh
and Al31S7 and the reaction to SNP was unchanged. There are also species
differencesin the effectof diabeteson contractile responses of arteries(Head et aL,
1987)which mayresultin part from changesin endothelium-depeudenrmechanisms.
Autonomicneuropathy is a commoncomplication in diabetes(Hoskinget at.,
1978). However,changesinperivascular innervation havenotbeen welldocumented.
Nochangein catecholamlnerg,c innervationwasfoundin cerebral vessels of diabetic
rats (Lagnado et aL, 1987). A substantial reduction of perivascular catecholaminergic
fibres has been found in the optic nerve of diabeticrats, but this was accompanied
byan increase in nerve density around bloodvesselsof the vagusand sciatic nerves
and the sympathetic chain (Dhital et aL, 1986). Sincechangesin sensory neurons
in diabetes have been reported (Sidenius andJakobsen, 1980) it is likelythat changes
inSP· andCGRP·containing perivascular nerve fibreswouldoccur. In cerebralblood
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vessels fromdiabeticrats no change in NPYinnervation was found (Lagnado et aL,
1987). A significant reduction of perivascular VIP innervation has been reported
in certainvesselbedsin diabetes. In streptozotocininduceddiabetes in the rat, the
density ifVIP· immunoreactive ne rve fibres was reduced in the inte rnal carot id, middle
cerebralandanteriorcerebral arteriesat8 weeksafterthe onsetofdiabetes (Lagnado
el 01., 1987). Reduction of VIP·immunoreactive nerves has also been found in
penile vascular tissue from 8 week streptoaotocin diabetic rats and from human
diabet ic patients with impotence (Crowe et al., 1983).
Atherosclerosis isa diseasein which manycomponents of the vascular system
may be affected, including the endothelium. Several studies have reported a
depression of endothelial derivedvasorelaxetion resultingfrom cholesterol feeding.
Variousmechanisms forthisobservedchangeinEDRFresponsehavebeensuggested.
It wasconcludedfromstudiesof human atherosclerotic arteriesand rabbit aorta that
thedefectinvolvedthemuscarinic receptorsof theendothelium (Bossaleret al., 1987).
Harrison and co-workers (1987) have made similarconclusions from studies of
atherosclerosis in monkeys.Moststudiesclaimthat the alterationiseither a reduction
in EDRF synthesis,or in cases with severe intimal thickening a reduced diffusion
of EORF. A studyby Jayakody and co-workers (1988)compared the effects of
cholesterol feedinginyoungand old rabbits. Despitesignificant structuraldifferences,
there wasa reduction in relaxationin bothgroups. It hasalso been suggestedthat
the amount of depressionof endothelium-dependent vasorelaxation is related to the
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severity of intimal lesions (Verbreuren et aL, 1986). It is therefore difficult to
conclude which of the vascular changesinvolved in atherosclerosis are responsible
for the observed reductionof EDRF activity.
It appears that the reduction in the ability of ACh to produce endo thelium-
dependent relaxations in capsaicin-treated rats is related to a change in either the
muscarinic receptor population, the ability to synthesize EDRF, or the ability of
the smooth muscle to relax. While thisdecreased EDRF response hasbeen observed
inhypertension, diabetes and atherosclerosis where changesare also known to occur
in perivascular innervation,it is not possible 10determine at this time if a common
mechanism such as denervation is responsible for this effect.
4.3. The Effect of 6-OHDA Treatment on the ACh Response
It has beenshown in this study that chemicalsympathectomywith 6-0 HDA
does not causea shift (If the ACh concentration responsecurve in the rat mesenteric
arterial bed (Figure 9, page 81). The trophic influence of the catecholaminergic
nerve fibre system on vascular tissues has been welldocumented (Aprigliano and
Hermsmeyer, 1977; Fronek, 1983: Bevan and Tsuru, 1981; Lee et aL. 1987j
Dlrrutriadou, eI aL, 1988). It is surprising then that removalof this nervefibre plexus
did not affectthe endothelium-dependent vasodilatoryresponse to ACh. The effect
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of sympathectomy on EDRF ability of b lood vessels has not been well s tudied.
Therefore there have been no reports as yet to substantiate this observatio n .
It was noti ced in this study that the pressor response to me thoxamine was
altered afte r6-0HDA treatment (FigureS. page75). Theperfusionpressurea ttained
with methoxaminein tissues from rats treated with 6-0HDA wassignificantly lower
thanthat foran equalconcentrationinuntrea tedor veblcle-treatedcontrols. A similar
decreased reactivityof the mesenteric arterialbed has been reportedfor noradrenaline
in spontaneously hypertensive rats, sympatheetomizedwith a combinationtre atment
of guanethidine and anti-nerve growth fa ct or (Lee et at. 1987). This decreased
reactivity to methoxamine is not thought to affect therelaxation response to ACh.
4.4. The Response to SP in the Mesente ric Bed
Sub stance Pwasoriginallyused inth is study as anaddi tionalagonsnc p roduce
an EDRF respo nse in the mesenteric arte rial bed. It was intended to compar e the
effectsof 6-0HDA and capsaicintreatmen ts onth e vasodilatory responseto SP with
those of ACh. H owever, administrationof S Presulted inan increased pressure above
that indu ced by methoxamine in the buffer. This pressor respo nse is a dose
depende nt effect in this tissue and is not affected byremoval of th e endothelium
(Figures ]0, 11. pages 82, 83). When th is presso r response was expressed as a
lOS
percentage potentiati onof the methoxamine response, W HOA treatment caused
an increase in the effect(Figure 14, page 87).
SPis known a s apoten t endothelium-de pendent vasodilator agent in a varie ty
of bloodvessels(Za wadzki et al., 1981; Furchgotlet aL, 1983). Its thr eshold for
activityin ma ny isolated blood vessels is in t he pioomolar range (Furchgolt et aL,
1983). In th is study doses of SPfrom 1 pmole 10 0.1 urroles were tested in the
meth oxamine constrictedpreparations. Relaxationsto SP were not seen at any dose,
while these preparati ons did give an EDRF response to 10'5 ACh in the perfusing
Iluid, Nomore than 2 doses of SP wer e administered to a tissue to avoid recep tor
desensitizationwhich couldmaskapotentialresponse. Thus, the perfused mesenteric
arterialbed didnot relaxin response to SP. Although SP hasbeen reported tocau se
endothelium-dependentrelaxations in ringprepa rations ofsuperiormesentericart e ry
(Ft...chgott et at, 1983), this effect might be hidden in thismore complex perfused
system. It has been report ed that SP does not cause relaxations in a perfused
mesenteric bed prepa ration (Gulatiet aL, 1982). Inadd ition.basedon studies with
a varietyof neuropep tides, G ardiner and colleagues (1987)have demonstrated that
different pepti descan affect different vascular bedsand that the same peptides can
have differe nt effects depending on the mode androut e ofadministrat ion.
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4.4.1. The Meclianism of Actionof SP in the MesentericBed
SubstancePhas beenshown to potentiate thevasoconstrictor responses induced
byNA in the isolated perfused mesenteric arterial bed o f the rat [Gulatiet aL, 1983~
In this study concentrations of SP from 4 x lO'9M to 4 x 1O-7M caused a dos e
dependentpotentiation of the NAinduced vasoconstrictor response. This effect was
blockedbythe useof saralasin, a specific antagonistof angiotensinII,suggesting thai
SPmighteithersimulat e or be modulatedbyangiotensinII. The useof indomethac in
in this study indicated that SP does not simulateor modulate the production of
prostaglandins toachieve its NApotentiating effect. It issuggestedthat SP may play
an important modulatoryrole in aorenergic vasoconstriction of the rat mesentery.
This study did notrule out the possibility tha t Sf mighthave a direct nonspecific
post synaptic sensitizingeffect on the vascular smooth muscle.
Inthis thesis the pressor response toSP wasalso foundto bedose dependent.
This response can be expressed as the absolutechangeinperfusion pressure o r as
a percentage potentiationof the methoxamine inducedpressure. SinceSPmayplay
a modulatory role in adrenergic vasoconstriction (Gulatiel al.; 1983), the pressor
responsewas calculated asa percentage increasein the methoxamine inducedpressure
measured just priorto injection ofSP. Theend otheliumdidnot seemto beinvolved
in this responsesince nochangewasobservedafter its removal (Figures 10,11,pages
82,83).
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In addition 10the observed pressor response toSP thisstudy has also found
that ne onatal 6-0HDA treatment results in an increase of this pressor re sponse
(Figure 14, page 87). Howmight 6-0 HDA cause tbise ffect? Th e desired effect
of6-0 HDA treatment in this tissue isremoval ofsympathe t ic innervation. As a result
theremaybecha nges in thepeptidergicinnervation duringdevelopment. An increase
inpeptidergic inn ervatio n hasbee nreported forguan ethidine induced sympathectomy
byAberdeen a n d co-workers ( 1987). As a result of these trophic interactions it is
possible that the reactivityof the mesenteric bed maybe altered . It has already
been shown in th is study thai a decreased reactivity 10 m et hoxamine resulte d from
6-OHDAtreatment. It hasalso beenshown that SP causesonlya verysmall increase
in press ure in th e presence of K· depolarizing buffer, th usruling out any major
contributionof a nonspecificaction on the smooth muscle memb rane (Figure 16.
page 90) . The e ffectof SPisabo unlikely tobe an indepen dent effect of act ivation
ofSP re ceptors on the smooth muscle, sinceSP caused no measurableresponsein
the absence of induced tonein the preparation. Therefore, it is possible that SP
may act onthe c-adrenoceptor at a sitedifferent from that occupied bymethoxamine
to cause its mo dulatory effect . In the case o f a decreased catecholaminergic
innervation and an increased pe ptidergic innerva tion, th is effect of SP might be
enhanced, result ingin an incre ased importance o f itsadr energic modulatory role.
However, thepo ssibnity ofSPactingviaan angiotensinII mechanism cannot be ruled
out as saralasin wasnot used In thisstudy. Furt her stud ieswith antagonists such
IIJ8
as saralasin and o theragonistssuch asS·HT would be required\0 fully charac terize
the pressor action ofSP in the mesenteric arterial bed.
4.5. Conclusion
Thi s thesis hasexamined the effects of catecholaminergic and pepridergic
denervationtreatmentson the actionsof AC hand SP inthe mesentericarterial bed
of the rat. It has shown that alte ration of the pep tidergic perivascular innervation
is accompanied by a decreased EDRFresponse to ACh and that changes in the
catecholaminergic fibres occur togetherwith anenh ancement of the SPmodulation
of adrenergicvasoconstric tion.
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